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A B S T R A C T
Background
Restorative proctocolectomy with ileo pouch anal anastomosis (IPAA) is the main surgical treatment for patients with ulcerative colitis
(UC) and familial adenomatous polyposis (FAP). With the advancements of minimal-invasive surgery this demanding operation is
increasingly being performed laparoscopically. Therefore, the presumed benefits of the laparoscopic approach need to be systematically
evaluated.
Objectives
To compare the beneficial and harmful effects of laparoscopic versus open IPAA for patients with UC and FAP.
Search methods
We searchedTheCochrane IBD/FBDGroup SpecializedTrial Register (April 2007), TheCochrane Library (Issue 1, 2007),MEDLINE
(1990 to April 2007), EMBASE (1990 to April 2007), ISI Web of Knowledge (1990 to April 2007) and the web casts of the American
Society of Colon and Rectal Surgeons (ASCRS) (up to 2006) for all trials comparing open versus laparoscopic IPAA.
Selection criteria
All trials in patients with UC or FAP comparing any kind of laparoscopic IPAA versus open IPAA. No language limitations were
applied.
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Data collection and analysis
Two authors independently performed selection of trials and data extraction. The methodological quality of all included trials was
evaluated to assess bias risk. Analysis of RCTs and non-RCTs was performed separately. Analyses were based on the intention-to-treat
principle. Authors were requested additional information in case of missing data. Sensitivity and subgroup analyses were performed if
appropriate.
Main results
Eleven trials included 607 patients of whom 253 (41%) in the laparoscopic IPAA group. Only one of the included trials was a
randomised controlled trial. There were no significant differences in mortality or complications between the two groups. Reoperation
and readmission rates were not significantly different. Operative time was significantly longer in the laparoscopic group both in the
RCT and meta-analysis of non-RCTs (weighted mean difference (WMD) 91 minutes; 95% Confidence Interval (CI) 53 to 130).
There were no significant differences between the two groups regarding postoperative recovery parameters. Total incision length was
significantly shorter in the laparoscopic group, while two trials evaluating cosmesis found significantly higher cosmesis scores in the
laparoscopic group. Other long-term outcomes were poorly reported.
Authors’ conclusions
The laparoscopic IPAA is a feasible and safe procedure. Short-term advantages of the laparoscopic approach seem to be limited and
their clinical significance is arguable. Large high-quality trials focusing on differences regarding specific postoperative complications,
cosmesis, quality of life and costs are needed.
P L A I N L A N G U A G E S U M M A R Y
Open versus laparoscopic approach to pouch surgery in patients with ulcerative colitis and familial adenomatous polyposis
showed no significant differences in mortality and complications, but the laparoscopic approach resulted in better cosmesis.
Resection of the entire colon and creation of an ileal pouch by means of an ileo pouch anal anastomosis (IPAA) is a last resort for many
patients with ulcerative colitis and familial adenomatous polyposis. In recent years this operation has increasingly being performed
laparoscopically. In this review we compared the open versus laparoscopic IPAA. We found no significant differences in mortality
and complications between the two techniques. The laparoscopic IPAA had a longer operative time of on average 90 minutes. No
reliable conclusions could be made regarding the benefit of laparoscopic IPAA on the postoperative recovery. Findings suggest that the
laparoscopic approach may improve the postoperative recovery, but the importance of these advantages seems limited. The laparoscopic
IPAA did result in better cosmesis than the open IPAA, but more studies will be needed to confirm these findings.
The most important limitation of this review is that we only found one randomised controlled trial (RCT) on this subject, and we
therefore needed to include non-randomised controlled trials. Another important limitation is that most studies did not report on
important long-term outcomes, like quality of life and functional outcome.
B A C K G R O U N D
Ulcerative colitis (UC) is an inflammatory disease of the large in-
testine of uncertain aetiology characterized by recurring episodes
of inflammation primarily involving the mucosal layer and occa-
sionally the submucosa of the colon. The estimated incidence of
UC is 8.7/100.000 in Europe (Shivananda 1996). Whereas medi-
cal treatment is themainstream for themanagement ofUC, several
evidence-based indications for surgical treatment have been iden-
tified, including acute pan colitis, intractability to medical treat-
ment and the presence of dysplasia or neoplasia (Cohen 2005).
Familial adenomatous polyposis (FAP) is a rare autosomal dom-
inant disease, characterized by the development of hundreds to
thousands of adenomatous polyps in the colon and rectum of af-
fected individuals leading to cancer at young age, if left untreated.
The incidence is around 2 permillion and the prevalence is around
40 per million (Bulow 2003; Jarvinen 1992). Because of the in-
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evitable development of cancer in this disease, colectomy is war-
ranted for all patients with FAP at a certain point of their disease.
Both UC and FAP are limited to the colon and rectum. Therefore,
proctocolectomy provides relief of symptoms and eliminates the
risk of developing colorectal cancer. Since its introduction in 1978
the restorative ileo pouch-anal anastomosis (IPAA) has gainedwide
acceptance in the surgical treatment of patients with UC and FAP
(Parks 1978). The open IPAA has become the standard surgical
approach for UC and FAP, due to its good functional results and
high patient satisfaction (Cohen 1992; Fazio 1995;Hueting 2005;
Marcello 1993).
Over the past decades laparoscopic techniques have evolved rapidly
and large bowel resections were increasingly being performed la-
paroscopically. The first laparoscopic-assisted restorative procto-
colectomy with IPAA (LA-IPAA) was described in 1992 (Peters
1992) and technical feasibility of this procedure has been shown
repeatedly (Casillas 2005; Ky 2002; Santoro 1999;Wexner 1992).
Reduced post-operative pain, quicker recovery and superior cos-
metic results are presumed advantages of the LA-IPAA over the
open IPAA. However, reports have shown inconsistent results.
Early reports tend to be sceptical with respect to the benefits of the
LA-IPAA (Reissman 1996; Sardinha 1998; Schmitt 1994), while
recent studies tend to show more favourable results of the laparo-
scopic technique (Gill 2004; Larson 2005; Marcello 2000).
As patients with UC and FAP requiring surgery generally are
young, active and highly motivated individuals, minimal-invasive
surgery may especially be appealing in this group of patients (Ky
2002). Cosmesis and patients’ satisfaction could therefore play im-
portant role in the choice between these two approaches.However,
possible benefits regarding these items is of secondary importance
compared to primary outcomes of surgery, like postoperative mor-
bidity and mortality.
To be able to compare both techniques in a satisfactory manner,
a systematic evaluation of the benefits and harms of open versus
LA-IPAA is needed.
O B J E C T I V E S
To studywhether laparoscopic and open IPAA forUC andFAP are
different in terms of primary (mortality and complications) and
secondary outcomes (operative time, hospital stay, convalescence,
cosmesis, functional outcome and quality of life). If data were
present, differences in other secondary outcomes were compared
as well.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Due to the paucity of randomised clinical trials, non-randomised
controlled clinical trials comparing open IPAA versus LA-IPAA
were also included in this review. Trials were included if they per-
formed a direct comparison of open IPAA versus LA-IPAA, irre-
spectively of randomisation, prospective data collection, number
of patients or language of the article.
Types of participants
Studies including patients with UC or FAP who underwent an
IPAA procedure were included. If studies sporadically included
patients with other diseases, theywere included as long as themain
population consisted of UC or FAP patients. Studies including
mainly patients with other diseases were excluded, unless they
presented the data for the UC and FAP patients separately. When
multiple studies have overlapping patient populations, only the
most recent publication was included in the review.
Types of interventions
Studies comparing any type of open IPAA to any type of LA-
IPAA were included. The following classification of the surgical
procedures (based on intention-to-treat) was used:
• ’Laparoscopic IPAA’ included those procedures started as a
laparoscopic procedure, with creation of any kind of
pneumoperitoneum (by Veress needle or open introduction) or
mechanical abdominal wall lift, irrespective of the number of
trocars used. ’Laparoscopic-assisted IPAA’ included those
procedures in which an additional small incision laparotomy was
used (e.g. Pfannenstiel or subumbilical midline incision) to
facilitate the laparoscopic IPAA procedure.
• In all other cases the surgical intervention was classified as
’open IPAA’.
Types of outcome measures
Primary outcome measures were mortality and complications (ex-
cept minor complications). Secondary outcome measures were all
other outcomes assessed in the comparison of the two operative
techniques. These included minor complications, operative time,
operative blood loss, time to bowelmovement, time to regular diet,
hospital stay, readmission rate, reoperation rate, incision length,
cosmesis, functional outcome (faecal and sexual function) and
costs.
Complications were classified into the following categories:
• Intraoperative complications: all complications occurring
and detected intraoperatively, like small bowel perforation and
severe intraoperative bleeding.
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• Procedure specific complications: pouch failure, pelvic
sepsis, pouch fistula, anastomotic leakage and strictures.
• Severe postoperative complications: e.g. intra-abdominal
abscesses, bleeding, sepsis, burst abdomen (Platzbauch) and
myocardial infarction.
• Mild postoperative complications: e.g. including prolonged
ileus, wound infections, urinary tract infections, urinary
retention, pleural effusion, late incisional hernia, and deep
venous thrombosis. Other postoperative complications were
categorized appropriately at first encounter.
• Total complications: the total number of all complications
per study.
The following definitions were used for the procedure specific
complications:
• Pouch failure: pouch excision or a non-functioning pouch
at 12 months after IPAA procedure.
• Pelvic sepsis: pelvic abscess, anastomotic leakage or
dehiscence or pelvic/perineal wound infection.
• Pouch fistula: any pouch related fistula.
• Stricture: anastomotic fibrosis necessitating dilatation.
Functional outcome was assessed using the following items:
• Defecation frequency: times of defecation per day, night or
per 24 hours.
• Mild faecal incontinence: soiling or spotting in underwear.
• Severe faecal incontinence: regularly severe leakage or faecal
loss or passive faecal incontinence.Urge faecal incontinence:
inability to defer defecation more than 15 minutes after first urge.
• Sexual dysfunction: retrograde ejaculation, erection
disorder or dyspareunia.
Search methods for identification of studies
We have searched the following databases:
• The Cochrane IBD/FBD Group Specialized Trial Register
(Non MEDLINE Records)
• The Cochrane Library (including The Cochrane Database
of Systematic Reviews, Database of Abstracts of Reviews of
Effects (DARE), The Cochrane Central Register of Controlled
Trials (CENTRAL), Health Technology Assessment (HTA)
Database, NHS Economic Evaluation Database) (Issue 1, 2007)
• MEDLINE (1990 to April 2007)
• EMBASE (1990 to April 2007)
• ISI Web of Knowledge (Web of Science) (1990 to April
2007)
• Web casts of the annual meetings of the American Society
of Colon and Rectal Surgeons (ASCRS)
For each database a specific search strategywas devised and adapted
to the syntax requirements of the respective database. The used
search strategies are listed in Table 1. Since the LA-IPAA was not
described before 1992 the search was started from the year 1990.
As a fall-safe strategy we pre-specified that if any eligible article
published before 1992was to be found, the searchwould have been
expanded to start from 1985. During the search no eligible articles
prior to 1992 were found, thus the search remained unchanged.
References of included trials and relevant reviews encountered
during the search were searched manually. Finally, all authors of
included trials were requested for additional information on any
published, unpublished or ongoing trials.
Data collection and analysis
The review was conducted according to the prespecified pro-
tocol (Ahmed Ali 2007) and the recommendations from the
Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2008).
Selection of studies
Titles of all retrieved articles were first screened by UAA or FK
and all obviously irrelevant reports were excluded. Subsequently,
abstracts of selected articles were reviewed by both UAA and FK
independently and differences were resolved by discussion with
CVL, if necessary. In case of any uncertainty, articles were always
selected for the subsequent step. Finally, the full-text of all selected
articles was reviewed by UAA and FK independently to determine
the eligibility of the article for this review. All included trials are
listed in the ’Characteristics of included studies’ table. Excluded
studies are listed in the ’Characteristics of excluded studies’ table
along with the reason for their exclusion.
Extraction of data
Two reviewers (UAA and FK or JH) independently extracted all
relevant data. For each study patient characteristics, study charac-
teristics, data needed for the methodological quality assessment of
the study and the primary and secondary outcomes were extracted
according to availability. Data regarding patient characteristics in-
cluded number of patients in each group, age, gender, BMI and
diagnoses of included patients. Data regarding study characteris-
tics included study design, sample size information, inclusion and
exclusion criteria of the study, follow-up period, loss to follow-up,
surgical experience and information regarding surgical techniques.
Individual authors were contacted if any essential data were miss-
ing.
Assessment of methodological quality of included studies
In this review both randomised controlled trials (RCTs) and non-
randomised controlled trials (non-RCTs) were included. For both
types a different assessment method was chosen.
Assessment of methodological quality of randomised clinical
trials
Based on the available empirical evidence (Higgins 2008;
Kjaergard 2001; Moher 1998; Schulz 1995) we assessed the
methodological quality of RCTs using the following items.
Generation of the allocation sequence
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Adequate, if the allocation sequence was generated by a computer
or random number table. Drawing of lots, tossing of a coin, shuf-
fling of cards, or throwing dice was considered as adequate if a
person who was not otherwise involved in the recruitment of par-
ticipants performed the procedure.
Unclear, if the trial was described as randomised, but the method
used for generation of the allocation sequence was not described.
Inadequate, if a system involving dates, names, or admittance
numbers was used for the allocation of patients.
Allocation concealment
Adequate, if the allocation of patients involved a central indepen-
dent unit, on-site locked computer, or sealed envelopes.
Unclear, if the trial was described as randomised, but the method
used to conceal the allocation was not described.
Inadequate, if the allocation sequence was known to the inves-
tigators who assigned participants or if the study was quasi-ran-
domised.
Blinding
Adequate, if the trial was described (at least) as blind to participants
or assessors and themethod of blinding was described.We are well
aware that it is very difficult to properly blind trials comparing
surgical treatments, therefore one level of blinding was considered
adequate.
Unclear, if the trial was described as (double) blind, but themethod
of blinding was not described.
Not performed, if the trial was not blinded.
Follow-up
Adequate, if the numbers and reasons for dropouts and with-
drawals in all intervention groups were described or if it was spec-
ified that there were no dropouts or withdrawals.
Unclear, if the report gave the impression that there had been no
dropouts or withdrawals, but this was not specifically stated.
Inadequate, if the number or reasons for dropouts andwithdrawals
were not described.
Assessment of methodological quality of non-randomised clin-
ical trials
Quality assessment for non-randomised clinical trials is a complex
topic and is generally considered to be an area of ongoing research
(Higgins 2008, section 6.8). In an extensive review of this topic (
Deeks 2003, chapter 4) investigators reviewed 193 tools for quality
assessment in literature, and concluded that based on quality and
design of these tools only 6 tools were suitable for use in systematic
reviews. They also concluded that all 6 tools needed some type of
modification before being fully suitable for that purpose.
In this review we used a modification of theMethodological Index
for Non-Randomised Studies (MINORS) (Slim 2003). This tool
is one of the few validated and tested methods specifically devel-
oped for the assessment of quality of non-randomised trials. To
adhere to the guidelines of the Cochrane Handbook the following
modifications were applied:
• Four of the 12 items of the MINORS were disregarded in
the quality assessment, because these items related to the
applicability, reporting quality, and precision of the results,
rather than the validity of the assessed trials (Higgins 2008,
section 6.7.2).
• Every item was used independently to distinguish between
high and low quality trials, rather than using the sum score of
this list. The draw-backs of using summary scores are the
decreased transparency to readers of the review and the evidence
showing that different scales could results in contradicting results
when applied in the same review (Juni 1999).
The modified MINORS list is outlined in Table 2. Every study
was assessed using this method by UAA and JH independently.
Discrepancies were solved by consensus discussion with a third
reviewer, CVL, if necessary.
Statistical analysis
Data from RCTs and non-RCT were analysed separately. With
adequate data available statistical analysis of binary data was con-
ducted using relative risks (RR) as the summary statistic. Trials
with zero events in both arms were excluded from meta-analyses.
However, a sensitivity analysis using risk differences (RD) was per-
formed with inclusion of these trials, and in case of inconsistency
the results of this sensitivity analysis were reported.
For continuous outcomes weighted mean differences (WMD)
were used as the summary statistic. Authors, however, often pre-
sented their results in medians with ranges due to suspicion of
skewed data, while means with their standard deviations (SD) are
needed for meta-analysis. Authors were contacted for additional
data if necessary. Additionally, sensitivity analyses imputing data
for missing means and standard deviations (calculated from avail-
able medians and ranges) were performed (Hozo 2005).
Heterogeneity was calculated usingHigginsχ2 -test and quantified
bymeasuring I2 (Higgins 2002). Aχ2-test with a P-value of < 0.10
was considered to indicate the presence of heterogeneity, while an
I2 > 50% was considered to suggest a marked inconsistency in
effect between studies. The fixed-effect model was only used if no
heterogeneity was present. In all other cases the random-effects
model was used. If excessive heterogeneity was present, data were
re-checked first. If heterogeneity persisted, subgroup or sensitivity
analyses were used to explore its causes. When adequate reasons
were present extreme outliers were excluded in sensitivity analyses.
In situations of excessive heterogeneity that could not be explained,
we refrained from reporting a pooled estimate.
Bias detection
Funnel plots were used to provide a visual assessment of whether
treatment estimates were associated with study size. This may help
identify the presence of publication or other type of biases (Begg
1994; Egger 1997; Macaskill 2001).
Subgroup and sensitivity analyses
Subgroup analyses were performed according to the methodolog-
ical quality of the included trials:
• For RCTs: adequate compared to unclear/inadequate
regarding the four quality criteria used to assess the
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methodological quality of RCTs.
• For non-RCTs: adequate compared to unclear/inadequate
regarding each item of the modified MINORS list on which the
studies differed.
Furthermore, causes of heterogeneity were explored by performing
sensitivity analysis based on surgical technique and other factors
that may explain heterogeneity.
Statistical analysis was conducted using the statistical package
(RevMan Analyses v. 5.0.16) provided by The Cochrane Collab-
oration and was performed by UAA, FK and CVL.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Search and trial identification
The systematic search was conducted in The Cochrane IBD/FBD
Group Specialized Trial Register (Non MEDLINE Records) (931
records, 0 selected), TheCochrane Library, Issue 1, 2007 (649 hits,
5 selected), The National Library of Medicine (MEDLINE) via
PubMed (4455 hits, 117 selected), Exerpta Medica via EMBASE
(6830 hits, 503 selected), ISI Web of Knowledge (1573 hits, 54
selected), and web casts of the annual meetings of the American
Society of Colon and Rectal Surgeons (ASCRS) (all published web
cast until 2006, 2 selected). For detailed information about the
search strategies and the numbers of hits we refer to additional
Table 1.
Altogether, the search resulted in 14,438 hits. The first selection
was performed based on the titles of publications and all clearly
irrelevant publications were excluded. A total of 679 hits were
considered possibly relevant based on their titles. After correction
for duplicates, 590 publications remained. The abstracts of these
590 publications were reviewed independently by two reviewers
(UAA and FK). Differences between UAA and FK were discussed
with CVL. A total of 552 publications could be rejected based on
their abstracts. Eventually, 37publicationswere selected for further
evaluation and these are listed in this review with reasons for in-
and exclusion. Studies that described series of LA-IPAAoperations,
without comparison to an open IPAA group were excluded and
are listed in the ’Characteristics of excluded studies’ table as well.
From the selected 37, a total of 25 publications were excluded
(see ’Characteristics of excluded studies’ table). Eleven publica-
tions were included (see ’Characteristics of included studies’ ta-
ble), and one protocol of an ongoing RCT was identified (see
’Characteristics of ongoing studies’ table). A cross-reference search
was performed of all included publications as well as five reviews
considered relevant to our review (Ballantyne 2004; Bemelman
1998; Chung 2003; Schwenk 2005; Tan 2006). This resulted
in the identification of one additional publication (Araki 2001).
Consequently, 12 publications were finally included in this review.
A flow-chart of the selection process is provided in Figure 1.
6Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. Flow-chart of the selection process
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Of these 12 publications, two described the short- and long-term
outcomes of a partially overlapping patient population (Larson
2005; Larson 2006). These publications were considered to be two
distinct trials, but data of only one of these two publications was
used in any single meta-analysis to prevent double reporting of
patients. Two other publications (Maartense 2004a; Polle 2007)
described the short- and long-term outcomes of the same trial.
These two publications were considered one trial and data was
handled accordingly. In summary, 12 publications, describing 11
trials were included in this review.
Finally, two publications (Berdah 2004; Otani 2001) were trans-
lated from French and Japanese, respectively (see acknowledge-
ment). Additional information on methodology was obtained re-
garding seven out of 11 trials and additional data (i.e. individ-
ual patient data) was obtained from two trials (Berdah 2004;
Maartense 2004a).
Patient characteristics
The 11 trials included 607 patients, of whom 253 (41%) in the
laparoscopic and 354 (59%) in the open IPAA group. A total of
516 (85%) patients suffered from UC and 89 (14,7%) from FAP.
Two studies exclusively included patients with UC (Araki 2001;
Otani 2001), whereas all other studies included both UC and FAP
patients. None of these studies presented the results of the UC and
FAP patients separately.
Trial designs
Of the 11 included trials, only one was a randomised controlled
trial (Maartense 2004a). Four of the 10 non-randomised trials
collected their data prospectively. The other 6 had retrospectively
data-collection or did not clearly specify this aspect. Ten trials had
a mono-centre design, and one trial was conducted in two centres
(Maartense 2004a). All trials, except one (Otani 2001), specified
that they performed their analysis according to the intention-to-
treat principle.
Surgical interventions
The types of performed surgical interventions varied between the
included trials. Eight trials compared the laparoscopic-assisted
IPAA (LA-IPAA) with the conventional open IPAA. The other
three trials compared slightly different types of procedures: one
trial (Brown 2001) compared the LA-IPAA with a mini-open
IPAA, another trial (Maartense 2004a) compared the laparoscopic
hand-assisted IPAA (HA-IPAA)with the conventional open IPAA,
and yet another trial (Larson 2006) compared a combined group
of LA-IPAA and HA-IPAA with the conventional open IPAA.We
considered all trials comparing procedures using a laparoscopic
technique versus open IPAA.
The HA-IPAA differs from the LA-IPAA in that the accessory in-
cision is performed at the start of the operation and covered with
an air sealed hand-port. Through this hand-port manual assis-
tance could be provided during the different stages of the opera-
tion. In general, HA-IPAA and LA-IPAA were performed using a
small Pfannenstiel incision, facilitating open rectum resection and
open creation of a J-pouch by means of a double-stapling tech-
nique to construct the ileo pouch anal anastomosis. Details of the
operative techniques used by the included trials are listed in the
’Characteristics of included studies’ table.
Outcome measures
Primary outcome measures, mortality and complications, were
well reported. Due to the brief follow-up period in most trials
mainly short-term complications were reported. Long-term out-
comes were reported by 4 trials only (Berdah 2004; Dunker 2001;
Larson 2005; Maartense 2004a ).
Secondary outcomes were reported variably . Based on availabil-
ity of data, meta-analysis was performed for complications, oper-
ative time, blood loss, time to bowel movement, time to regular
diet, hospital stay, re-operation rate and incision length. Cosmesis,
functional outcome and costs were reviewed without meta-analy-
sis.
Risk of bias in included studies
Since only one RCT was identified all trials, including the RCT,
were assessed using themodifiedMINORS.Differenceswere iden-
tified regarding three items only:
• Prospective collection of data: five trials (45%) scored
’adequate’ and six trials (55%) scored ’unclear / inadequate’.
• Contemporary groups of cases and controls: seven trials
(64%) scored ’adequate’ and four trials (36%) scored ’unclear /
inadequate’.
• Baseline equivalence of groups: seven trials (64%) scored
’adequate’ and the four trials (36%) scored ’inadequate’.
Only three trials, including the RCT, scored adequate for these
three items. Detailed methodological assessment of trials is listed
in Table 3.
Effects of interventions
Characteristics of the included trials are shown in Table 4. Baseline
characteristics of included patients are shown in Table 5.
Meta-analysis of RCTs was not feasible, since only one RCT
(Maartense 2004a) was identified. An overview of the results of
this RCT are presented in Table 6. When adequate data was avail-
able, a meta-analysis of the non-randomised trials was performed.
In this meta-analysis five comparisons were conducted. In three
comparisons trials were subdivided into subgroups of high- and
low-quality trials based on the three methodological quality cri-
teria. In the fourth comparison trials meeting all three method-
ological criteria (highest-quality trials) were set against all other
trials. The fifth comparison contained additional sensitivity anal-
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yses.The findings of the RCTs as well as the results of the meta-
analysis of non-RCTs are presented below.
No significant differenceswere observed regardingmortality, intra-
operative complications, procedure specific complications, severe
complications, minor complications, readmission and reoperation
rate in any of the performed comparisons.
Mortality
Mortality was not reported in two trials (Hashimoto 2001; Otani
2001). In the nine trials reporting mortality a total of 232 patients
and 323 patients were included in the laparoscopic and the open
group, respectively. Eight trials reported zero mortality in both
groups. With one death in the open group (Araki 2001), there was
no statistically significant difference.
Intraoperative complications
Intraoperative complications were reported by 5 trials including
130 and 230 patients in the laparoscopic and open groups, respec-
tively. The RCT by Maartense (Maartense 2004a) and the study
by Larson (Larson 2006) reported one intraoperative complica-
tion in each group, while three trials reported zero intraoperative
complications. No significant differences were observed between
the two groups .
Procedure specific complications
Procedure specific complications were reported in 8 trials, with
2 trials reporting zero complications. The RCT reported 4/30
(13%) and 6/30 (20%) complications in the laparoscopic and
open group, respectively (not statistically significant). Five non-
RCTs were pooled showing 6/132 (4.5%) procedure specific com-
plications in the laparoscopic group and 6/224 (2.7%) in the open
group. Differences were not statistically significant (Relative risk
(RR) 0.81; 95% confidence interval (CI) 0.32 to 2.02). Hetero-
geneity was not present.
Severe complications
Severe complications were reported in 9 trials, with 3 trials re-
porting zero complications.The RCT reported 0/30 (0%) and
2/30 (7%) severe complications in the laparoscopic and open
group, respectively (not statistically significant). Five non-RCTs
were pooled showing 8/157 (5.1%) severe complications in the
laparoscopic group and 20/258 (7,8%) in the open group. Differ-
ences were not statistically significant (RR 0.65; 95% CI 0.29 to
1.48). Heterogeneity was not present.
Minor complications
Minor complications were reported in 9 trials. The RCT reported
9/30 (30%) and 7/30 (23%) minor complications in the laparo-
scopic and open group, respectively (not statistically significant).
Eight non-RCTs were pooled. There were 59/213 (27.7%) minor
complications in the laparoscopic group and 83/306 (27.1%) in
the open group. Differences were not statistically significant (RR
1.05; 95% CI 0.78 to 1.41). No significant heterogeneity was
present.
Total complications
Total complications consisted of the sum of all complications in
the aforementioned categories. The RCT showed 14/30 (47%)
and 16/30 (53%) total complications in the laparoscopic and open
group, respectively (not statistically significant). Eight non-RCTs
with 213 patients in the laparoscopic group and 306 patients in
the open group were pooled. A total of 80 (37.6%) complications
in the laparoscopic group and 127 (41.5%) in the open group
were observed. There were no significant differences between the
two groups (RR 0.91; 95% CI 0.73 to 1.14). No heterogeneity
was observed between the studies. In a funnel plot on total com-
plications we did not find arguments for bias (Figure 2).
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Figure 2. Funnel plot of trials reporting total complications, including 95% confidence interval lines. There
are no indications for bias.
Operative time
Operative time was reported in 10 trials, but only five provided
data in means with their standard-deviations. Both the RCT and
the pooled non-RCTs showed a significantly longer operative time
for the laparoscopic procedure. The RCT showed an increase in
themedian operative time from133 (range 97 to 260) for the open
IPAA to 214 (range 149 to 400) for the laparoscopic approach (p=
<0.001). Themeta-analysis of four non-RCTs included58patients
in each group and showed a significantly longer operative time
in the laparoscopic group (weighted mean difference (WMD) 92
minutes; 95%CI 53 to 130). The random-effects model was used,
since substantial heterogeneity was present (χ2=11.02 (p=0.01),
I2=73%).
Sensitivity analysis imputing data for missing values included 223
and 324 patients in the laparoscopic and open groups, respectively,
and confirmed the findings of the primary meta-analysis (WMD
82 minutes; 95% CI 60 to 105). Heterogeneity remained signifi-
cant (χ2=36.30 (p<0.0001), I2=75.2%). Further exploring of data
in subgroup analyses did not identify clear causes for the observed
heterogeneity.
Blood loss
Operative blood loss was reported by five trials. The RCT reported
no difference between the two groups with a median blood loss
of 263 mL (range 75 to 1200) in the laparoscopic and 300 mL
(range 50 to 800) in the open group (p=0.98). Two non-RCTs
provided data in means and SDs and were pooled. The meta-
analysis included 31 and 29 patients in the laparoscopic and open
groups, respectively. There was no significant difference in blood
loss between the two techniques (WMD -99 mL; 95% CI -261 to
64). As heterogeneity was present, the random-effects model was
applied (χ2 =2.70 (p<0.10), I2=63.0%).
A sensitivity analysis imputing data for two more trials included
62 patients in each group and did show a significant reduction
in blood loss using the laparoscopic technique (WMD -138 mL;
95% CI -235 to -41). Adding these two extra trials reduced het-
erogeneity significantly (χ2=4.57 (p<0.21), I2=34.4%).
Time to bowel movement
Time to bowel movement was reported by three non-RCTs. All
trials found a significant shorter time to bowel movement in the
laparoscopic group. Data of only one trial was provided in means
and standard-deviations (Araki 2001). Therefore, only pooled data
from a sensitivity analyses imputing data for means and SD from
the two other trials was available. This analysis included 141 and
231 patients in the laparoscopic and open group, respectively, and
showed a significant shorter time to bowel movement in the la-
paroscopic group (WMD -1.96 days; 95%CI -3.45 to -0.46). The
random-effects model was used, since heterogeneity was present
(χ2=6.74 (p=0.03), I2=70%).
Time to regular diet
Time to regular diet was reported by six trials. The RCT showed
a median of 6 days (range 4 to 19) in the laparoscopic and 7 days
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(range 4-15) in the open group (p=0.6). Only two non-RCTs in-
cluding 25 and 35 patients in the laparoscopic and open groups,
respectively, provided data in means and standard-deviations. No
significant difference between both groups was found when pool-
ing these trials (WMD -2.72 days, 95% CI -8.33 to 2.88).
A sensitivity analysis with imputed data including three additional
trials, with a total of 148 patients in the laparoscopic and 261
patients in the open group, did result in a significant difference
in favour of the laparoscopic group (WMD -1.47 days; 95% CI -
2.25 to -0.69). No significant heterogeneity was present.
Hospital stay
Hospital stay was reported by 9 trials. The RCT showed no sig-
nificant difference between the two groups, with a median stay of
10 days (range 5 to 13) in the laparoscopic and 11 days (range
6-28) in the open group. Four non-RCTs, including 48 patients
in the laparoscopic and 40 in the open group, presented data in
means with SD. Pooling these trials showed a significantly shorter
hospital stay for the laparoscopic procedure compared to the open
technique (WMD -2.66 days; 95% CI -4.28, -1.04). No hetero-
geneity was present.
A sensitivity analysis using imputed data included five additional
trials, with a total of 213 patients in the laparoscopic and 306
in the open group. This sensitivity analysis showed a significant
shorter hospital stay for the laparoscopic group as well (WMD -
2.12 days; 95% CI -3.12 to -1.12). The random-effects model
was used, since heterogeneity was present (χ2 =12.33 (p=0.09), I
2=43%).
Readmission rate
Readmission rate was reported by two trials. The RCT reported
5/23 (22%) and 3/23 (13%) readmissions in the laparoscopic
and open group, respectively. Larson 2006 found 21/100 (21%)
readmissions in the laparoscopic and 44/200 (22%) in the open
group. Both studies showed no significant difference between the
two groups.
Reoperation rate
Re-operation rate was reported by seven trials. The RCT reported
5/30 (17%) reoperations in both groups (not statistically signifi-
cant). Six non-RCTs were pooled. There were 7/172 (4,0%) reop-
erations in the laparoscopic and 16/275 (5,8%) in the open group.
Differences were not statistically significant (RR 0.74; 95% CI
0.32 to 1.71). No significant heterogeneity was present.
Incision length
Incision length was reported by two studies (Brown 2001, Dunker
2001). Both studies showed a significant smaller incision length
for the laparoscopic group. Since only one trial provided means
and SDs, nometa-analysis was performed. Sensitivity analysis with
imputed data, including 27 patients in the laparoscopic and 30
patients in the open group, showed a significantly shorter incision
in the laparoscopic group as well (WMD -7.79 cm; 95% CI -9.68
to -5.9). There was no heterogeneity present.
Cosmesis
Cosmesis scores were reported by two trials (Dunker 2001;
Maartense 2004a). Both studies used the same cosmesis scale and
both showed significantly higher cosmesis scores in the laparo-
scopic group. The RCT showed a significant increase from a mean
of 14.7 points in the open group to 18.5 in the laparoscopic groups
(SD not reported, p=0.01). The study by Dunker 2001 reported
an increase from a mean of 16 (4.6) points in the open to 19.8
(4.6) in the laparoscopic group (p=0.03).
Functional outcome
Defecation frequency
Defecation frequency was reported by four trials. However, pool-
ing data was not possible due to inconsistencies in reporting of
results. All available data of these four trials are presented in Table
7. The defecation frequency was reported by three trials (1 RCT
and 2 non-RCTs) per day and night separately, all with a follow-
up period of at least 12 months. One trial (Otani 2001) reported
the defecation frequency per 24 hours at discharge. No signifi-
cant differences were reported between the two groups by any of
the four trials. Two sensitivity analyses imputing missing data for
non-RCTs reporting the defecation frequency per day and night
separately, showed no significant differences as well.
Faecal incontinence
Four trials (Berdah 2004; Dunker 2001; Maartense 2004a) re-
ported on this outcome. Every study used its own classification
for faecal incontinence and pooling results was not possible. None
of the four trials found any significant difference between the two
groups regarding daytime continence, overnight continence, soil-
ing, urge incontinence, or any of the used measure of faecal con-
tinence.
Sexual function
Sexual function was reported by three trials (Dunker 2001; Larson
2005; Maartense 2004a). All trials measured and reported sexual
function differently. None of these trials identified a significant
difference between the laparoscopic and open group regarding this
outcome as well.
Costs
Only one trial (Maartense 2004a) reported on differences in costs
between the laparoscopic and open IPAA (Table 7). Operative
costs were significantly higher in the laparoscopic group. How-
ever, when the overall total costs (including costs for hospital stay,
relaparotomies and readmission, etc) were analysed no significant
difference was found.
D I S C U S S I O N
This systematic review evaluatingdifferences between laparoscopic
and open IPAAprocedures shows several important findings. First,
only one randomised trial has been conducted so far on LA-IPAA
versus open IPAA. Therefore, lower level evidence had to be in-
cluded in this review with consequently an increased risk for in-
troducing bias. Second, no significant differences were found in
the primary outcome measures: mortality and complications. Also
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readmission and reoperation rates were not significantly different.
Third, laparoscopic IPAA is associated with a significantly longer
operative time. Fourth, presumed short-term benefits of the LA-
IPAA regarding convalescence could not be confirmed reliably.
Fifth, follow-up periods of most studies were inappropriate for
evaluation of long-term outcomes.
This review has encountered several methodological problems.
First, by including non-randomised studies the risk for bias and
its influence on false conclusions is considerable (Deeks 2003).
Non-randomised trials have a higher risk of bias, due to lack of
standardized protocols, unclear methodology, high risk of selec-
tion bias and inability to match for all confounders. Moreover,
the methodological quality of most included trials was moderate
or poor. For example, only 3 out of the 10 non-randomised trials
collected their data prospectively and had a sufficient level of base-
line equivalence between the two groups. However, these lower
level evidence studies are the best we have so far. While future
research is obviously needed, we hope that by reviewing this evi-
dence systematically we can provide clinicians with a balanced un-
derstanding of the present evidence and its possible implications.
Methodological quality assessment of non-randomised trials has
proved to be problematic as well. Contrary to RCTs, little evidence
exists regarding important items in themethodological assessment
of non-randomised trials. Moreover, few validated scales and lists
exist for this purpose and there is no consensus regarding the
tool of choice. The MINORS index, chosen for its validation
and simplicity, proved to have its own shortcomings as well. It
was liable to confuse the validity of trials with other items like
quality of reporting and precision of results, and it used a summary
score to indicate the overall quality of trials. Both properties have
important drawback and their use is discouraged by the Cochrane
guidelines (Higgins 2008, 6.7.2). The applied modifications did
solve these problems, but they also may have undermined the
validity of the scale. Empirical evidence regarding methodological
criteria influencing reliability of the results of non-randomised
trials is needed for better assessment of this type of trials.
Another problem that faced this review was the paucity of data
regarding several outcomes. This was caused by the relatively small
number of available trials, but also by the small numbers of patiens
in every trial and the limited amount of data suitable for meta-
analysis. Especially the latter pointwas of considerable importance.
For several continuous outcomes less thenhalf of the available trials
could be included in the meta-analysis. This could undermine the
reliability of results, as illustrated by the inconsistent results of
the meta-analysis and the sensitivity analysis with imputed data,
seen in several outcomes. Additionally, most trials had a short
follow-upperiod, usually until discharge, whichmade it difficult to
evaluate important long-term outcomes, like functional outcome
and quality of life.
During the conduct of this review another meta-analysis compar-
ing open versus laparoscopic IPAA was published (Tilney 2007).
General conclusions of this meta-analysis were quite similar to
ours, although there were some important differences. First, the
search strategy performed was less extensive and limits were ap-
plied for the study type in PUBMED. This resulted in failure to
identify two relevant trials (Berdah 2004; Otani 2001). Secondly,
this meta-analysis included just over half the numbers of patients
included in our meta-analysis (329 compared to 607), mainly due
to a large trial (Larson 2006) which was published recently. Also,
two trials were included in thismeta-analysis that were excluded by
us for having partial overlap in patients with other included trials
(Wexner 1992; Young-Fadok 2001). The last important difference
is that the authors imputed means and standard deviations using
medians and ranges in their meta-analyses without specification in
the methods section. Some of their findings were therefore partly
based on imputed data and may very well be biased.
The absence in this review of differences between the open and
laparoscopic IPAA considering the primary outcomes, mortality
and complications, suggests that the LA-IPAA is a feasible and
safe procedure. This is in accordance to the results of several rela-
tive large series of LA-IPAA published recently (Kienle 2005; Ky
2002). However we have to emphasize that the number of in-
cluded patients is rather low to be able to detect all clinically rele-
vant differences. Especially detailed evaluation of individual com-
plications, like wound infections or late incisional hernia that may
benefit from a minimal invasive approach, is not possible based
on the available data.
Regarding postoperative recovery, this review could not reliable
identify clinically significant benefits of the laparoscopic approach.
Hospital stay was shorter for the laparoscopic approach in both
the meta-analysis of non-RCTs (WMD -2.7 days) and the sen-
sitivity analysis with imputed data (WMD -2.1 days). However,
this was not supported by the result of the RCT. One explana-
tion could be that the RCT used a hand-assisted approach for the
laparoscopic IPAA, while most other trials used a laparoscopic-
assisted approach (see Description of studies - Surgical interven-
tions). Sensitivity analyses imputing missing data also suggested
that the laparoscopic technique was associated with less blood loss,
time to bowel movement and time to regular diet. As proved by
these inconsistent findings, more data is needed before a final word
could be said regarding this matter.
A point worth considering is that the clinical relevance of such rel-
atively small benefits regarding the postoperative recovery remains
questionable. With a complex operation like the IPAA a one or a
two day reduction of hospital stay is not likely to be decisive in
the choice of operative technique. Neither will be a slightly faster
normalization of bowel function or return to normal diet. Espe-
cially with the increased implementation of ’fast-track’ periopera-
tive care programs, the differences between open and laparoscopic
techniques could diminish even further. ’Fast-track’ programmes
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have already been applied in a wide variety of colonic operations
and results seem to confirm there ability to accelerate recovery,
reduce morbidity and shorten hospital stay (Wind 2006). In time,
implementation of such programs even in complex procedures,
like the IPAA, seems likely. Therefore, future studies comparing
open and laparoscopic IPAA should probably focus on other clin-
ically more relevant outcomes, like specific complications, costs
and long-term outcomes.
One of the most relevant long-term outcomes is maybe the cos-
metic result of surgery and its impact in this predominately young
group of patients. In this review, two trials showed a significantly
shorter incision in the laparoscopic IPAA. Also, two trials re-
ported results of cosmesis and body image. Both trials observed
significantly higher scores regarding cosmesis in the laparoscopic
group. Additionally, in the long-term follow-up of the only RCT
(Maartense 2004a) body image scores in female patients were
found to be significantly higher in the laparoscopic group. These
results suggest that the shorter incision of the laparoscopic ap-
proach is associated with long-lasting benefits in the perception
of patients of their own body, which could be an interesting argu-
ment in favour of the laparoscopic technique. While these results
need conformation from other trials, the social and psychologi-
cal impact could be significant. With an ever increasing patient’s
awareness a smaller scar and improved cosmesis could be impor-
tant factor in guiding the choice of operative technique in clinical
practice.
Costs also play an important role when evaluating new operative
techniques, since fear of increased costs could be a strong mo-
tive against their implementation. In this review only one trial
(Maartense 2004a) reported on costs and found no significant dif-
ferences when the overall costs, including admission, complica-
tions and readmission, were evaluated. The costs of the laparo-
scopic procedure was, however, significantly higher than the open
technique. Trials comparing costs of other types of colonic surgery
give contradicting results: some trials show no differences in costs
between laparoscopic and open approaches (Pokala 2005), while
others show results favouring the laparoscopic approach (Senagore
1993). It is therefore not possible to draw reliable conclusion from
these studies and future research is required to resolve this issue as
well.
In this context the ongoing LapCon-Pouch Trial (Antolovic 2006)
is an important step in the right direction. This single-centre, pa-
tient blinded trial will randomise 160 patients into two groups:
a totally laparoscopic IPAA group and a conventional open IPAA
group. This trial will be the largest randomised clinical trial and
will have the largest number of total laparoscopic IPAA patients
included in any report so far. It will have the power to answer sev-
eral interesting question and with a follow-up period of 12 month
more light could be shed on important long-termoutcomes.While
the sample-size is not large enough to resolve all issues, it should
be noted that for a relatively infrequent operation as the IPAA a
sample of this size is substantial. It is therefore to be hoped that
other high-volume centres will follow the example of this trial and
that in the near future a meta-analysis based solely on RCTs would
become feasible.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The laparoscopic IPAA is a safe procedure, that could be performed
successfully in centres experienced in laparoscopic and restorative
pouch surgery. The laparoscopic approach seems to be associated
with some short-term advantages regarding postoperative recov-
ery, but these advantages seem to be limited and their clinical sig-
nificance is arguable. For a complex operation like the IPAA other
outcomes, like specific complications, long-term functional out-
come, cosmesis and costs are more likely to influence the choice of
the operative technique. This review have shown that for cosmesis
there are some data favouring the laparoscopic approach, but that
the evidence is still inconclusive and more research is needed be-
fore a general recommendation can be made. There is also some
evidence that costs, a crucial item in today’s health care, may not
become a decisive item in the decision between open and laparo-
scopic IPAA.
Implications for research
High volume colorectal surgical centres should include patients
scheduled for laparoscopic IPAA in high-quality RCTs with suf-
ficiently long follow-up to be able to reliable assess differences
in relevant long-term outcomes. The focus of these trials should
be specific postoperative complications, cosmesis, quality of life
and costs.Trials should provide data suitable for meta-analysis in
there published publications, or at least make it readily available
upon request. There is need for empirical evidence to guide the
process of methodological quality assessment of non-randomised
controlled trials.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Araki 2001
Methods - Mono-center trial
- N = 32 (21 cases, 11 controls)
- Collection of data: retrospective.
- Matching: no (base-line equal)
- Contemporary groups: no (controls from 1990 to 1994 and cases from 1994 to 1999)
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculation: no
Participants Diangosis: UC only
In- and exclusion criteria: all patients undergoing IPAA procedures in the period of study
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: 7 cm incision along the lower abdomen, J-pouch, double-stapled, without diverting loop
ileostomy.
- Open IPAA: not specified.
Surgical experience: not described.
Outcomes Primary and secondary outcomes: not stated.
Measured outcomes: mortality, postoprative complications, operative time, time to removal of nasogastric




Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Berdah 2004
Methods - Mono-center trial
- N = 24 (12 cases, 12 controls)
- Collection of data: prospective
- Matching: matched for age, gender, BMI and diagnosis.
- Contemporary groups: yes
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculation: no
Participants Diagnosis: UC and FAP.
In- and exclusion criteria: first 6 patients on basis of favorable morphology. After that all IPAA patients
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Berdah 2004 (Continued)
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: through Pfannenstiel incisionwith unspecified length, J-pouch, double-stapled, with diverting
loop ileostomy for all.
- Open IPAA: midline incision from xephoid till symphesis, J-pouch, double-stabled, with diverting loop
ileostomy for all
Surgical experience: not described.
Outcomes Primary and secondary outcomes: not stated.
Measured outcomes: mortality, postoprative complications, conversion, operative time, length of incision,
start of ileostomy function, commencement of diet, length of hospital stay
Follow-up: > 3 years
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Brown 2001
Methods - Mono-center trial
- N = 25 (cases 12, controls 13)
- Collection of data: retrospective
- Matching: not matched
- Contemporary groups: no
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculation: no
Participants Diagnosis: UC, FAP and 1 rectal cancer (LA group)
In- and exclusion criteria: all LA-IPAA and subsequently all mini-open IPAA
Interventions LA-IPAA vs Mini-Open IPAA.
- LA-IPAA: through short suprapubic incision of unspecified length, J-pouch, double-stapled anastomosis,
with diverting loop ileostomy.
- Mini-Open IPAA: suprapubic incision of variable length, using an illuminated St. Mark’s retractor to
facilitate the mobilization, J-pouch, double-stapled anastomosis, with diverting loop ileostomy
Surgical experience: claim to have large experience in laparoscopic colonic surgery. No specific data is
presented
Outcomes Primary and secondary outcomes: not very well descriped.
Measured outcomes: mortality, postoprative complications, conversion, operative time, length of incision,
start of ileostomy function, commencement of diet, length of hospital stay
Follow-up: till discharge
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Brown 2001 (Continued)
Notes - Performed a mini-open IPAA technique.
- Included one patient with juvenile polyposis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Dunker 2001
Methods - Mono-center trial
- N = 32 (cases 15, controls 17)
- Collection of data: retrospective
- Matching: matched for follow-up duration, type of disease and type of operation (1- or 2-stages).
- Contemporary groups: yes
- Loss to follow-up: 2/35 (5.7%)
- Intention to treat: yes
- Sample size calculation: no
Participants Diagnosis: UC and FAP
In- and exclusion criteria: all LAP-IPAA in periode of study, who agreed to participate and fill out the
necessary forms
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: through Pfannenstiel incision with unspecified length, J-pouch, type of anastomosis not
specified, no diverting loop ileostomy for all. Some patients had the operation in 2-stages (an emergency
LA-total collectomy and ileostomy followed by a proctectomy with IPAA later on).
- Open IPAA: midline incision from xephoid till symphesis, J-pouch, anastomosis type not specified, no
diverting loop ileostomy for all. Some had a 2-stage operation.
Surgical experience: not described.
Outcomes Primary and secondary outcomes: not very well descriped.
Measured outcomes: functional outcome: questenaire focusing on feacal function and sexual activity;
quality of life using the SF-36 and GIQLI; Body image and cosmesis: body image questionnaire; Other
outcomes: mortality, postoperative complications, conversion, length of operation, length of incision,
time to intake > 1000 ml, time to regular diet, time to pouch drain > 100ml, length of hospital stay,
relaparotomy
Follow-up: variable, mean 16 month.
Notes
Risk of bias
Item Authors’ judgement Description
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Dunker 2001 (Continued)
Allocation concealment? Unclear D - Not used
Hashimoto 2001
Methods - Mono-center trial
- N = 24 (cases 11, controls 13)
- Collection of data: retrospective
- Matching: not matched
- Contemporary groups: no
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculation: no
Participants Diagnosis: UC and FAP
In- and exclusion criteria: all LAP-IPAA in periode of study (indication for LAP-IPAA are well described)
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: through Pfannenstiel of 6 to 8 cm, J-pouch, with mucosectomy and hand-sewn, with diverting
loop ileostomy for all.
-Open IPAA: incision type and length not specified, J-pouch,mucosectomy andhand-sewn,with diverting
loop ileostomy for all
Surgical experience: not described.
Outcomes Primary and secondary outcomes: not very well descriped.
Measured outcomes: mortality, intra- and postoperative complications, conversion, operative time, in-





Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
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Larson 2005
Methods - Mono-center trial
- N = 66 (cases 33, controls 33)
- Collection of data: prospective
- Matching: matched for age, gender, date of surgery, BMI and indication.
- Contemporary groups: yes
- Loss to follow-up: 0 (4 of eligible 37 didn’t return the standard annual survey, therefore not included in
study)
- Intention to treat: yes
- Sample size calculation: no
Participants Diagnosis: UC and FAP
In- and exclusion criteria: all LAP-IPAA in periode of study, with a follow-up > 12 months
Interventions LA-IPAA vs open IPAA.
- LA-IPAA: through periumbilical of 4 to 5 cm, J-pouch, either mucosectomy and handsewn or double-
stapled, with diverting loop ileostomy in majority (30/33)
- Open IPAA: type en length of incision: not mentioned, J-pouch, either mucosectomy and handsewn or
double-stapled, with diverting loop ileostomy in all
Surgical experience: not specified.
Outcomes Primary and secondary outcomes: not well described.
Measured outcomes: mortality, posoperative complications, reoperation, rate of use of diverting ileostomy,
faecal function and sexual activity
Follow-up: > 12 months.
Notes - Focus on longterm outcomes (shortterm outcomes published separately)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Larson 2006
Methods - Mono-center trial
- N = 300 (cases 100, controls 200)
- Collection of data: cases prospective, controls retrospective
- Matching: matched for age, gender, date of surgery, BMI and procedure.
- Contemporary groups: yes
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculation: no
Participants Diagnosis: UC and FAP
In- and exclusion criteria: all LAP-IPAA in periode of study
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Larson 2006 (Continued)
Interventions LA-IPAA and HA-IPAA vs open IPAA.
- LA-IPAA: through periumbilical, low midline or Pfannenstiel incision of 4 to 5 cm, J-pouch, either
handsewn or double-stapled, with diverting loop ileostomy.
- HA-IPAA: through lower midline or Pfannenstiel incision of 6 to 8 cm, J-Pouch, either handsewn
mucosectomy or double-Stapled, with diverting loop ileostomy .
- Open IPAA: type en length of incision: not mentioned, J-pouch, either mucosectomy or double-stapled,
with diverting loop ileostomy
Surgical experience: LAP-IPAA: large experience in laparoscopic surgery, but most surgeons are new to
LAP-IPAA. Open-IPAA: collective large experience in open IPAA
Outcomes Primary and secondary outcomes: not stated.
Measured outcomes: intraoperative complications, postoperative complications (bowel obstruction,
wound infection, intra-abdominal abscesses, pulmonary infections, ileus, UTI, urinary retention, anasto-
motic leak, readmission and cause of readmission, surgical reintervention), mortality, duration of opera-
tion, conversion rate to open, time to bowel movement, time to regular diet, postoperative use of analgesic,
length of hospital stay.
Follow-up: 90 days
Notes - Both LA-IPAA and HA-IPAA.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Maartense 2004a
Methods - Two-centre trial.
- N = 60 (30 cases, 30 controls)
- Generation of allocation: unclear
- Allocation concealment: adequate (sealed envelope).
- Blinding: not performed.
- Follow-up: adequate.
- Loss to follow up:
-- Maartense 2004: 2 in HA-IPAA, 3 in open group.
-- Polle 2007: 7 in HA-IPAA, 7 in open group.
- Intention-to-treat: yes
- Sample size calculations: yes
Participants Diagnosis: UC and FAP
In- and exclusion criteria: well described.
Interventions HA-IPAA vs open IPAA.
-HA-IPAA: through Pfannenstiel incision of 8 cm, J-Pouch, double-Stapled, with diverting loop ileostomy
on surgeon’s discretion.
- Open IPAA: median incision of unspecified length, J-pouch, double-stapled, with diverting loop
ileostomy on surgeon’s discretion
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Maartense 2004a (Continued)
Surgical experience: good experience in both laparoscopic colorectal surgery and open IPAA
Outcomes Primary and secondary outcomes: well described.
Measured outcomes: postoperative recovery, operating time, blood loss, conversion rate, morphine re-
quirement, mortality, early complications, early readmissions and reoperations, costs and short-term qual-
ity of life (SF-36 & GIQLI)
Follow-up:
- Maartense 2004: 3 months.
- Polle 2007: 2.7 years.
Notes - Long-term outcomes published separately (Polle 2007)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Marcello 2000
Methods - Mono-center trial
- N = 40 (20 cases, 20 control)
- Collection of data: prospective
- Matching: matched for age, gender, diagnosis, BMI and severity of MUC (albumine, Hb, WCC, steroid
requirements and indication for surgery)
- Contemporary groups: yes
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculations: no
Participants Diagnosis: UC and FAP
In- and exclusion criteria: all LAP-IPAA in periode of study
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: through Pfannenstiel incision of 6 to 8 cm, pouch-configuration: not mentioned, double-
stapled, with diverting loop ileostomy for all but one patient with MUC and without ileostomy for all
FAP. - Open IPAA: type and length of incision and pouch-configuration not mentioned, double-stapled
anastomosis, with diverting loop ileostomy for all MUC and without for all FAP
Surgical experience: good experience in laparoscopic colorectal surgery (>700 cases), including total ab-
dominal colectomies (>100). However, new in LAP-IPAA
Outcomes Primary and secondary outcomes: not stated.
Measured outcomes: intraoperative complications, postoperative complications, conversion rate, estimated
blood loss, operative time, time to bowel function, length of hospital stay, rate of use of diverting ileostomy
Follow-up: till discharge.
Notes
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Marcello 2000 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Otani 2001
Methods - Mono-center trial
- N = 28 (10 cases, 18 control)
- Collection of data: not specified
- Matching: not matched
- Contemporary groups: yes
- Loss to follow-up: 0
- Intention to treat: ns
- Sample size calculations: no
Participants Diagnosis: UC only
In- and exclusion criteria: all LAP-IPAA and Open IPAA performed till that time
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: through midline incision of 6 to 7 cm, J-pouch, double-stapled, without a diverting loop
ileostomy.
- Open IPAA: type and length of incision, pouch-configuration and type of anastomosis not specified. A
diverting ileostomy is used when the patient uses > 30 mg/day corticosteroids
Surgical experience: new in LAP-IPAA.
Outcomes Primary and secondary outcomes: not stated.
Measured outcomes: estimated blood loss, time to oral feeding, operative time, length of hospital stay,




Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
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Schmitt 1994
Methods - Mono-center trial
- N = 42 (22 cases, 20 control)
- Collection of data: prospective
- Matching: matched for age, gender and diagnosis
- Contemporary groups: yes
- Loss to follow-up: 0
- Intention to treat: yes
- Sample size calculations: no
Participants Diagnosis: UC, FAP and 1 juvenile polyposis (LA-group)
In- and exclusion criteria: all LAP-IPAA in periode of study
Interventions LA-IPAA vs Open IPAA.
- LA-IPAA: through Pfannenstiel incision of unspecified length, J-Pouch, double-stapled anastomosis,
with diverting loop ileostomy .
- Open IPAA: type and length of incision not mentioned, J-pouch, double-stapled anastomosis, with
diverting loop ileostomy
Surgical experience: not specified.
Outcomes Primary and secondary outcomes: not stated.
Measured outcomes: mortality, postoperative complications, operative time, blood transfusion require-
ment, time clearance of ileus, time to first oral intake, length of hospital stay, reoperation rate
Follow-up: till discharge.
Notes - Included one patient with juvenile polyposis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
IPAA=restorative proctocolectomy with ileal-pouch anal anastomosis. LA-IPAA= laparoscopic-assisted IPAA. HA-IPAA= hand-assisted
IPAA. N=number of patients.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Araki 2000 Descriptive series, with no control group.
Araujo 2005 Descriptive series, with no control group.
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(Continued)
Baccari 2000 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Delaney 2003 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Dunker 2000 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Etienne 1993 No abstract was found in the electronic databases, therefore the full publications was obtained. This showed
that no IPAA were performed
Georgeson 2002 The full article showed that this was mainly a theoretical review, with a brief description of clinical experience
without presentation of outcomes
Gill 2004 Descriptive series, with no control group.
Hahnloser 2004 This study had an overlapping patient population with a subsequent study from the same institution (Larson
2006)
Hasegawa 2002 Descriptive series, with no control group.
Hildebrandt 1998 Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full
article revealed that there was no control group in this study
Hong 2002 Abstract did not specify type of operations performed. Reviewing the full article revealed that only 2 out of the
279 patients included in this study had an IPAA
Ishida 2003 Abstract did not specify type of operations performed. Reviewing the full article revealed that 4 of the 7 patients
in this study did not underwent an IPAA procedure
Kessler 2001 Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full
article revealed that there was no control group in this study
Kienle 2003 Descriptive series, with no control group.
Kienle 2005 Descriptive series, with no control group.
Ky 2002 Descriptive series, with no control group.
Larach 1993 No abstract was found in the electronic databases, therefore the full article has been retrieved. This showed that
there were no IPAA’s performed
Lindemann 1995 Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full
article revealed that there was no control group in this study
Liu 1995 Descriptive series, with no control group.
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(Continued)
Maartense 2004b While the emergency colectomy was performed laparoscopically, the IPAA that has been done after a multiple
month recovery periode was performed open in both groups
Marcello 2001 Abstract did not specify types of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Nogueras 1992 No abstract was available. Reviewing the full article revealed that there was no control group in this study
Ouaissi 2006 Abstract did not specify wether the laparoscopic group was compared to an open group . Reviewing the full
article revealed that there was no control group in this study
Pace 2002 Descriptive series, with no control group.
Panis 2005 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Pfeifer 1995 Abstract did not specify type of operations performed. Reviewing the full article revealed that out of the 106
patients included in this study, only 2 had undergone a laparoscopic-assisted IPAA
Santoro 1999 Descriptive series, with no control group.
Senagore 1993 Abstract did not specify type of operations performed. Reviewing the full article didn’t reveal any explicit
mention of IPAA. Furthermore this study included patients with a large variety of diseases and the final analyses
was made for all patients together
Seow 1999 This study had an overlapping patient population with a subsequent study from the same institution (Brown
2001)
Seshadri 2001 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Stocchi 2000 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Vignali 2004 Abstract did not specify type of operations performed. Reviewing the full article revealed that no IPAAs were
performed
Wexner 1992 A preliminary study with partially overlapping patients with a subsequent trial of the same institution (Schmitt
1994)
Wexner 1996 Descriptive series, with no control group.
Young-Fadok 2001 This study had an overlapping patient population with a subsequent study from the same institution (Larson
2006)
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Characteristics of ongoing studies [ordered by study ID]
Antolovic 2006
Trial name or title LapConPouch-Trial: Totally Lparoscopic versus Conventional Ileoanal Pouch Procedure
Methods
Participants 160 patients (80 per intervention arm) with ulcerative colitis or familial adenomatous polyposis, requiring
restorative proctocolectomy
Interventions Totally laparoscopic versus conventional
open restorative proctocolectomy.
Outcomes Blood loss, operative time, early and late onset complications, postoperative pain and analgesic drug use,
length of hospital stay, lung function, quality of life (SF-36), body image and cosmesis
Starting date September 2004,with a duration of 4 years.
Contact information Corresponding author: Seiler - christoph seiler@med.uni-heidelberg.de.
Department of Surgery, University of Heidelberg, Heidelberg, Germany.
Christoph M
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection




participants Statistical method Effect size
1 Procedure specific complications 5 420 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.32, 2.02]
1.1 High-quality trials 2 64 Risk Ratio (M-H, Fixed, 95% CI) 0.6 [0.08, 4.30]
1.2 Low-quality trials 3 356 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.32, 2.51]
2 Severe postoperative
complications
5 415 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.29, 1.48]
2.1 High-quality trials 2 66 Risk Ratio (M-H, Fixed, 95% CI) 2.85 [0.46, 17.50]
2.2 Low-quality trials 3 349 Risk Ratio (M-H, Fixed, 95% CI) 0.41 [0.15, 1.13]
3 Minor complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.78, 1.41]
3.1 High-quality trials 3 106 Risk Ratio (M-H, Fixed, 95% CI) 2.14 [1.01, 4.54]
3.2 Low-quality trials 5 413 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.64, 1.23]
4 Total Complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.14]
4.1 High-quality trials 3 106 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.87, 2.44]
4.2 Low-quality trials 5 413 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.63, 1.04]
5 Operative time (minutes) 4 116 Mean Difference (IV, Random, 95% CI) 91.52 [53.36, 129.
68]
5.1 High-quality trials 1 24 Mean Difference (IV, Random, 95% CI) 97.5 [66.17, 128.83]
5.2 Low-quality trials 3 92 Mean Difference (IV, Random, 95% CI) 83.03 [21.45, 144.
61]
6 Blood loss (mL) 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
6.1 Low-quality trials 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
7 Time to regular diet (days) 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
7.1 Low-quality trials 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
8 Hospital stay (days) 3 88 Mean Difference (IV, Fixed, 95% CI) -2.66 [-4.28, -1.04]
8.1 High-quality trial 1 24 Mean Difference (IV, Fixed, 95% CI) -2.98 [-7.11, 1.15]
8.2 Low-quality trial 2 64 Mean Difference (IV, Fixed, 95% CI) -2.60 [-4.37, -0.84]
9 Reoperation 6 447 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.32, 1.71]
9.1 High-quality trials 2 66 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.14, 6.62]
9.2 Low-quality trials 4 381 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.28, 1.78]
Comparison 2. LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups




participants Statistical method Effect size
1 Procedure specific complications 5 420 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.32, 2.02]
1.1 High-quality trials 3 364 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.14, 2.77]
1.2 Low-quality trials 2 56 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.31, 3.16]
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2 Severe postoperative
complications
5 415 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.29, 1.48]
2.1 High-quality trials 3 366 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.26, 1.60]
2.2 Low-quality trials 2 49 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.09, 4.79]
3 Minor complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.78, 1.41]
3.1 High-quality trials 5 438 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.71, 1.38]
3.2 Low-quality trials 3 81 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.70, 2.68]
4 Total Complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.14]
4.1 High-quality trials 5 438 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.68, 1.13]
4.2 Low-quality trials 3 81 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.68, 1.77]
5 Operative time (minutes) 4 116 Mean Difference (IV, Random, 95% CI) 91.52 [53.36, 129.
68]
5.1 High-quality trials 2 56 Mean Difference (IV, Random, 95% CI) 116.12 [82.00, 150.
25]
5.2 Low-quality trials 2 60 Mean Difference (IV, Random, 95% CI) 58.57 [17.76, 99.38]
6 Blood loss (mL) 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
6.1 Low-quality trials 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
7 Time to regular diet (days) 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
7.1 High-quality trials 1 32 Mean Difference (IV, Fixed, 95% CI) -1.40 [-2.64, -0.16]
7.2 Low-quality trials 1 28 Mean Difference (IV, Fixed, 95% CI) -8.90 [-20.79, 2.99]
8 Hospital stay (days) 3 88 Mean Difference (IV, Fixed, 95% CI) -2.66 [-4.28, -1.04]
8.1 High-quality trial 2 56 Mean Difference (IV, Fixed, 95% CI) -2.66 [-4.28, -1.03]
8.2 Low-quality trial 1 32 Mean Difference (IV, Fixed, 95% CI) -3.20 [-24.65, 18.
25]
9 Reoperation 6 447 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.32, 1.71]
9.1 High-quality trials 4 398 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.23, 1.57]
9.2 Low-quality trials 2 49 Risk Ratio (M-H, Fixed, 95% CI) 1.87 [0.27, 13.04]
Comparison 3. LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence




participants Statistical method Effect size
1 Procedure specific complications 5 420 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.32, 2.02]
1.1 High-quality trials 4 396 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.24, 1.79]
1.2 Low-quality trials 1 24 Risk Ratio (M-H, Fixed, 95% CI) 3.5 [0.16, 78.19]
2 Severe postoperative
complications
5 415 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.29, 1.48]
2.1 High-quality trials 3 349 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.17, 1.23]
2.2 Low-quality trials 2 66 Risk Ratio (M-H, Fixed, 95% CI) 2.03 [0.36, 11.37]
3 Minor complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.78, 1.41]
3.1 High-quality trials 5 421 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.63, 1.24]
3.2 Low-quality trials 3 98 Risk Ratio (M-H, Fixed, 95% CI) 1.97 [1.01, 3.84]
4 Total Complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.14]
4.1 High-quality trials 5 421 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.62, 1.03]
4.2 Low-quality trials 3 98 Risk Ratio (M-H, Fixed, 95% CI) 1.56 [0.95, 2.56]
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5 Operative time (minutes) 4 116 Mean Difference (IV, Random, 95% CI) 91.52 [53.36, 129.
68]
5.1 High-quality trials 2 56 Mean Difference (IV, Random, 95% CI) 68.63 [-7.05, 144.
30]
5.2 Low-quality trials 2 60 Mean Difference (IV, Random, 95% CI) 103.02 [41.06, 164.
99]
6 Blood loss (mL) 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
6.1 High-quality trials 1 32 Mean Difference (IV, Random, 95% CI) -18.00 [-149.51,
109.51]
6.2 Low-quality trials 1 28 Mean Difference (IV, Random, 95% CI) -186.0 [-335.65, -
36.35]
7 Time to regular diet (days) 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
7.1 Low-quality trials 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
8 Hospital stay (days) 3 88 Mean Difference (IV, Fixed, 95% CI) -2.66 [-4.28, -1.04]
8.1 High-quality trial 2 56 Mean Difference (IV, Fixed, 95% CI) -2.99 [-7.04, 1.07]
8.2 Low-quality trial 1 32 Mean Difference (IV, Fixed, 95% CI) -2.60 [-4.37, -0.83]
9 Reoperation 6 447 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.32, 1.71]
9.1 High-quality trials 3 349 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.18, 1.41]
9.2 Low-quality trials 3 98 Risk Ratio (M-H, Fixed, 95% CI) 2.14 [0.41, 11.25]
Comparison 4. LA-IPAA vs Open-IPAA - highest-quality trials versus other trials




participants Statistical method Effect size
1 Procedure specific complications 5 420 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.32, 2.02]
1.1 High-quality trials 2 64 Risk Ratio (M-H, Fixed, 95% CI) 0.6 [0.08, 4.30]
1.2 Low-quality trials 3 356 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.32, 2.51]
2 Severe postoperative
complications
5 415 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.29, 1.48]
2.1 High-quality trials 1 24 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.07, 14.21]
2.2 Low-quality trials 4 391 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.26, 1.49]
3 Minor complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.78, 1.41]
3.1 High-quality trials 2 64 Risk Ratio (M-H, Fixed, 95% CI) 1.2 [0.40, 3.57]
3.2 Low-quality trials 6 455 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.76, 1.41]
4 Total Complications 8 519 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.14]
4.1 High-quality trials 2 64 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.43, 2.34]
4.2 Low-quality trials 6 455 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.72, 1.14]
5 Operative time (minutes) 4 116 Mean Difference (IV, Random, 95% CI) 91.52 [53.36, 129.
68]
5.1 High-quality trials 1 24 Mean Difference (IV, Random, 95% CI) 97.5 [66.17, 128.83]
5.2 Low-quality trials 3 92 Mean Difference (IV, Random, 95% CI) 83.03 [21.45, 144.
61]
6 Blood loss (mL) 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
6.1 Low-quality trials 2 60 Mean Difference (IV, Random, 95% CI) -98.59 [-261.04, 63.
86]
7 Time to regular diet (days) 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
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7.1 Low-quality trials 2 60 Mean Difference (IV, Fixed, 95% CI) -1.48 [-2.71, -0.25]
8 Hospital stay (days) 3 88 Mean Difference (IV, Fixed, 95% CI) -2.66 [-4.28, -1.04]
8.1 High-quality trial 1 24 Mean Difference (IV, Fixed, 95% CI) -2.98 [-7.11, 1.15]
8.2 Low-quality trial 2 64 Mean Difference (IV, Fixed, 95% CI) -2.60 [-4.37, -0.84]
9 Reoperation 6 447 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.32, 1.71]
9.1 High-quality trials 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.45]
9.2 Low-quality trials 5 423 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.33, 1.91]
Comparison 5. LA-IPAA vs Open-IPAA - sensitivity analsyses




participants Statistical method Effect size
1 Sensitivity analysis 1: Imputing
means and standard deviations
in operative time (minutes)
9 547 Mean Difference (IV, Random, 95% CI) 82.66 [59.99, 105.
33]
2 Sensitivity analysis 2: Imputing
means and standard deviations
in blood loss (mL)
4 124 Mean Difference (IV, Random, 95% CI) -137.75 [-234.64, -
40.86]
3 Sensitivity analysis 3: Imputing
means and standard deviations
in time to bowel movement
(days)
3 372 Mean Difference (IV, Random, 95% CI) -1.96 [-3.45, -0.46]
4 Sensitivity analysis 4: Imputing
means and standard deviations
in time to regular diet (days)
5 409 Mean Difference (IV, Random, 95% CI) -1.47 [-2.25, -0.69]
5 Sensitivity analysis 5: Imputing
means and standard deviations
in hospital stay (days)
8 519 Mean Difference (IV, Random, 95% CI) -2.12 [-3.12, -1.12]
6 Sensitivity analysis 6: Imputing
means and standard deviations
in incision length (cm)
2 57 Mean Difference (IV, Fixed, 95% CI) -7.79 [-9.68, -5.90]
7 Sensitivity analysis 8: Imputing
means and standard deviations
in defecation frequency day
(times/day)
2 98 Mean Difference (IV, Random, 95% CI) 0.19 [-1.38, 1.76]
8 Sensitivity analysis 9: Imputing
means and standard deviations
in defecation frequency night
(times/night)
2 98 Mean Difference (IV, Random, 95% CI) -0.66 [-1.35, 0.03]
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Analysis 1.1. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 1 Procedure specific complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 1 Procedure specific complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 16.9 % 0.33 [ 0.01, 7.45 ]
Marcello 2000 1/20 1/20 11.2 % 1.00 [ 0.07, 14.90 ]
Subtotal (95% CI) 32 32 28.1 % 0.60 [ 0.08, 4.30 ]
Total events: 1 (LA-IPAA), 2 (Open-IPAA)
Heterogeneity: Chi2 = 0.27, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
2 Low-quality trials
Araki 2001 4/21 3/11 44.2 % 0.70 [ 0.19, 2.58 ]
Hashimoto 2001 1/11 0/13 5.2 % 3.50 [ 0.16, 78.19 ]
Larson 2006 1/100 3/200 22.5 % 0.67 [ 0.07, 6.33 ]
Subtotal (95% CI) 132 224 71.9 % 0.89 [ 0.32, 2.51 ]
Total events: 6 (LA-IPAA), 6 (Open-IPAA)
Heterogeneity: Chi2 = 0.94, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.83)
Total (95% CI) 164 256 100.0 % 0.81 [ 0.32, 2.02 ]
Total events: 7 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 1.27, df = 4 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
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Analysis 1.2. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 2 Severe postoperative complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 2 Severe postoperative complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 1/12 1/12 6.6 % 1.00 [ 0.07, 14.21 ]
Schmitt 1994 3/22 0/20 3.4 % 6.39 [ 0.35, 116.57 ]
Subtotal (95% CI) 34 32 10.0 % 2.85 [ 0.46, 17.50 ]
Total events: 4 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: Chi2 = 0.90, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
2 Low-quality trials
Brown 2001 1/12 1/13 6.3 % 1.08 [ 0.08, 15.46 ]
Hashimoto 2001 0/11 1/13 9.1 % 0.39 [ 0.02, 8.69 ]
Larson 2006 3/100 17/200 74.6 % 0.35 [ 0.11, 1.18 ]
Subtotal (95% CI) 123 226 90.0 % 0.41 [ 0.15, 1.13 ]
Total events: 4 (LA-IPAA), 19 (Open-IPAA)
Heterogeneity: Chi2 = 0.58, df = 2 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.72 (P = 0.086)
Total (95% CI) 157 258 100.0 % 0.65 [ 0.29, 1.48 ]
Total events: 8 (LA-IPAA), 20 (Open-IPAA)
Heterogeneity: Chi2 = 3.72, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
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Analysis 1.3. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 3 Minor complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 3 Minor complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 3/12 1/12 1.6 % 3.00 [ 0.36, 24.92 ]
Marcello 2000 3/20 4/20 6.3 % 0.75 [ 0.19, 2.93 ]
Schmitt 1994 12/22 3/20 5.0 % 3.64 [ 1.20, 11.04 ]
Subtotal (95% CI) 54 52 12.9 % 2.14 [ 1.01, 4.54 ]
Total events: 18 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 3.25, df = 2 (P = 0.20); I2 =38%
Test for overall effect: Z = 1.99 (P = 0.047)
2 Low-quality trials
Araki 2001 7/21 4/11 8.3 % 0.92 [ 0.34, 2.46 ]
Brown 2001 1/12 0/13 0.8 % 3.23 [ 0.14, 72.46 ]
Dunker 2001 1/15 3/17 4.5 % 0.38 [ 0.04, 3.26 ]
Hashimoto 2001 6/11 4/13 5.8 % 1.77 [ 0.67, 4.71 ]
Larson 2006 26/100 64/200 67.7 % 0.81 [ 0.55, 1.20 ]
Subtotal (95% CI) 159 254 87.1 % 0.89 [ 0.64, 1.23 ]
Total events: 41 (LA-IPAA), 75 (Open-IPAA)
Heterogeneity: Chi2 = 3.40, df = 4 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Total (95% CI) 213 306 100.0 % 1.05 [ 0.78, 1.41 ]
Total events: 59 (LA-IPAA), 83 (Open-IPAA)
Heterogeneity: Chi2 = 10.20, df = 7 (P = 0.18); I2 =31%
Test for overall effect: Z = 0.31 (P = 0.76)
0.01 0.1 1 10 100
Favours LA-IPAA Favours Open-IPAA
37Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.4. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 4 Total Complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 4 Total Complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 4/12 3/12 3.1 % 1.33 [ 0.38, 4.72 ]
Marcello 2000 4/20 5/20 5.1 % 0.80 [ 0.25, 2.55 ]
Schmitt 1994 15/22 7/20 7.5 % 1.95 [ 1.00, 3.78 ]
Subtotal (95% CI) 54 52 15.8 % 1.45 [ 0.87, 2.44 ]
Total events: 23 (LA-IPAA), 15 (Open-IPAA)
Heterogeneity: Chi2 = 1.79, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 1.41 (P = 0.16)
2 Low-quality trials
Araki 2001 11/21 7/11 9.5 % 0.82 [ 0.45, 1.51 ]
Brown 2001 2/12 2/13 2.0 % 1.08 [ 0.18, 6.53 ]
Dunker 2001 1/15 3/17 2.9 % 0.38 [ 0.04, 3.26 ]
Hashimoto 2001 7/11 5/13 4.7 % 1.65 [ 0.73, 3.76 ]
Larson 2006 36/100 95/200 65.2 % 0.76 [ 0.56, 1.02 ]
Subtotal (95% CI) 159 254 84.2 % 0.81 [ 0.63, 1.04 ]
Total events: 57 (LA-IPAA), 112 (Open-IPAA)
Heterogeneity: Chi2 = 3.69, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.63 (P = 0.10)
Total (95% CI) 213 306 100.0 % 0.91 [ 0.73, 1.14 ]
Total events: 80 (LA-IPAA), 127 (Open-IPAA)
Heterogeneity: Chi2 = 9.73, df = 7 (P = 0.20); I2 =28%
Test for overall effect: Z = 0.80 (P = 0.42)
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Analysis 1.5. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 5 Operative time (minutes).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 5 Operative time (minutes)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 High-quality trials
Berdah 2004 12 402.5 (35.96) 12 305 (42.1) 30.0 % 97.50 [ 66.17, 128.83 ]
Subtotal (95% CI) 12 12 30.0 % 97.50 [ 66.17, 128.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.10 (P < 0.00001)
2 Low-quality trials
Araki 2001 21 215 (141) 11 198 (112) 12.2 % 17.00 [ -72.54, 106.54 ]
Dunker 2001 15 292.3 (39) 17 159.9 (35) 32.1 % 132.40 [ 106.59, 158.21 ]
Otani 2001 10 377 (58.8) 18 308 (46.9) 25.7 % 69.00 [ 26.60, 111.40 ]
Subtotal (95% CI) 46 46 70.0 % 83.03 [ 21.45, 144.61 ]
Heterogeneity: Tau2 = 2244.88; Chi2 = 10.63, df = 2 (P = 0.005); I2 =81%
Test for overall effect: Z = 2.64 (P = 0.0082)
Total (95% CI) 58 58 100.0 % 91.52 [ 53.36, 129.68 ]
Heterogeneity: Tau2 = 1008.13; Chi2 = 11.02, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 4.70 (P < 0.00001)
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Analysis 1.6. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 6 Blood loss (mL).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 6 Blood loss (mL)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Low-quality trials
Araki 2001 21 218 (268) 11 238 (102) 52.7 % -20.00 [ -149.51, 109.51 ]
Otani 2001 10 177 (142) 18 363 (262) 47.3 % -186.00 [ -335.65, -36.35 ]
Total (95% CI) 31 29 100.0 % -98.59 [ -261.04, 63.86 ]
Heterogeneity: Tau2 = 8680.02; Chi2 = 2.70, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.19 (P = 0.23)
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Analysis 1.7. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 7 Time to regular diet (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 7 Time to regular diet (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-quality trials
Otani 2001 10 10.3 (3.5) 18 19.2 (25.3) 1.1 % -8.90 [ -20.79, 2.99 ]
Dunker 2001 15 5.6 (1.3) 17 7 (2.2) 98.9 % -1.40 [ -2.64, -0.16 ]
Total (95% CI) 25 35 100.0 % -1.48 [ -2.71, -0.25 ]
Heterogeneity: Chi2 = 1.51, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 8 Hospital stay (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 8 Hospital stay (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High-quality trial
Berdah 2004 12 11.92 (3.68) 12 14.9 (6.3) 15.4 % -2.98 [ -7.11, 1.15 ]
Subtotal (95% CI) 12 12 15.4 % -2.98 [ -7.11, 1.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.41 (P = 0.16)
2 Low-quality trial
Araki 2001 21 36.1 (31.4) 11 39.3 (28.3) 0.6 % -3.20 [ -24.65, 18.25 ]
Dunker 2001 15 9.9 (2.4) 17 12.5 (2.7) 84.0 % -2.60 [ -4.37, -0.83 ]
Subtotal (95% CI) 36 28 84.6 % -2.60 [ -4.37, -0.84 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 2.90 (P = 0.0038)
Total (95% CI) 48 40 100.0 % -2.66 [ -4.28, -1.04 ]
Heterogeneity: Chi2 = 0.03, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
-10 -5 0 5 10
Favours LA-IPAA Favours Open-IPAA
41Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.9. Comparison 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
prospective data collection, Outcome 9 Reoperation.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 1 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding prospective data collection
Outcome: 9 Reoperation
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 11.5 % 0.33 [ 0.01, 7.45 ]
Schmitt 1994 1/22 0/20 4.0 % 2.74 [ 0.12, 63.63 ]
Subtotal (95% CI) 34 32 15.5 % 0.96 [ 0.14, 6.62 ]
Total events: 1 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: Chi2 = 0.87, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
2 Low-quality trials
Brown 2001 1/12 1/13 7.4 % 1.08 [ 0.08, 15.46 ]
Dunker 2001 1/15 1/17 7.2 % 1.13 [ 0.08, 16.59 ]
Hashimoto 2001 1/11 0/13 3.5 % 3.50 [ 0.16, 78.19 ]
Larson 2006 3/100 13/200 66.4 % 0.46 [ 0.13, 1.58 ]
Subtotal (95% CI) 138 243 84.5 % 0.70 [ 0.28, 1.78 ]
Total events: 6 (LA-IPAA), 15 (Open-IPAA)
Heterogeneity: Chi2 = 1.70, df = 3 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
Total (95% CI) 172 275 100.0 % 0.74 [ 0.32, 1.71 ]
Total events: 7 (LA-IPAA), 16 (Open-IPAA)
Heterogeneity: Chi2 = 2.62, df = 5 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.70 (P = 0.48)
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Analysis 2.1. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 1 Procedure specific complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 1 Procedure specific complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 16.9 % 0.33 [ 0.01, 7.45 ]
Larson 2006 1/100 3/200 22.5 % 0.67 [ 0.07, 6.33 ]
Marcello 2000 1/20 1/20 11.2 % 1.00 [ 0.07, 14.90 ]
Subtotal (95% CI) 132 232 50.6 % 0.63 [ 0.14, 2.77 ]
Total events: 2 (LA-IPAA), 5 (Open-IPAA)
Heterogeneity: Chi2 = 0.28, df = 2 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.61 (P = 0.54)
2 Low-quality trials
Araki 2001 4/21 3/11 44.2 % 0.70 [ 0.19, 2.58 ]
Hashimoto 2001 1/11 0/13 5.2 % 3.50 [ 0.16, 78.19 ]
Subtotal (95% CI) 32 24 49.4 % 0.99 [ 0.31, 3.16 ]
Total events: 5 (LA-IPAA), 3 (Open-IPAA)
Heterogeneity: Chi2 = 0.91, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Total (95% CI) 164 256 100.0 % 0.81 [ 0.32, 2.02 ]
Total events: 7 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 1.27, df = 4 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
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Analysis 2.2. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 2 Severe postoperative complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 2 Severe postoperative complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 1/12 1/12 6.6 % 1.00 [ 0.07, 14.21 ]
Larson 2006 3/100 17/200 74.6 % 0.35 [ 0.11, 1.18 ]
Schmitt 1994 3/22 0/20 3.4 % 6.39 [ 0.35, 116.57 ]
Subtotal (95% CI) 134 232 84.6 % 0.65 [ 0.26, 1.60 ]
Total events: 7 (LA-IPAA), 18 (Open-IPAA)
Heterogeneity: Chi2 = 3.47, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 0.94 (P = 0.35)
2 Low-quality trials
Brown 2001 1/12 1/13 6.3 % 1.08 [ 0.08, 15.46 ]
Hashimoto 2001 0/11 1/13 9.1 % 0.39 [ 0.02, 8.69 ]
Subtotal (95% CI) 23 26 15.4 % 0.67 [ 0.09, 4.79 ]
Total events: 1 (LA-IPAA), 2 (Open-IPAA)
Heterogeneity: Chi2 = 0.24, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
Total (95% CI) 157 258 100.0 % 0.65 [ 0.29, 1.48 ]
Total events: 8 (LA-IPAA), 20 (Open-IPAA)
Heterogeneity: Chi2 = 3.72, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
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Analysis 2.3. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 3 Minor complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 3 Minor complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 3/12 1/12 1.6 % 3.00 [ 0.36, 24.92 ]
Dunker 2001 1/15 3/17 4.5 % 0.38 [ 0.04, 3.26 ]
Larson 2006 26/100 64/200 67.7 % 0.81 [ 0.55, 1.20 ]
Marcello 2000 3/20 4/20 6.3 % 0.75 [ 0.19, 2.93 ]
Schmitt 1994 12/22 3/20 5.0 % 3.64 [ 1.20, 11.04 ]
Subtotal (95% CI) 169 269 85.1 % 0.99 [ 0.71, 1.38 ]
Total events: 45 (LA-IPAA), 75 (Open-IPAA)
Heterogeneity: Chi2 = 8.25, df = 4 (P = 0.08); I2 =52%
Test for overall effect: Z = 0.05 (P = 0.96)
2 Low-quality trials
Araki 2001 7/21 4/11 8.3 % 0.92 [ 0.34, 2.46 ]
Brown 2001 1/12 0/13 0.8 % 3.23 [ 0.14, 72.46 ]
Hashimoto 2001 6/11 4/13 5.8 % 1.77 [ 0.67, 4.71 ]
Subtotal (95% CI) 44 37 14.9 % 1.37 [ 0.70, 2.68 ]
Total events: 14 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 1.19, df = 2 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
Total (95% CI) 213 306 100.0 % 1.05 [ 0.78, 1.41 ]
Total events: 59 (LA-IPAA), 83 (Open-IPAA)
Heterogeneity: Chi2 = 10.20, df = 7 (P = 0.18); I2 =31%
Test for overall effect: Z = 0.31 (P = 0.76)
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Analysis 2.4. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 4 Total Complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 4 Total Complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 4/12 3/12 3.1 % 1.33 [ 0.38, 4.72 ]
Dunker 2001 1/15 3/17 2.9 % 0.38 [ 0.04, 3.26 ]
Larson 2006 36/100 95/200 65.2 % 0.76 [ 0.56, 1.02 ]
Marcello 2000 4/20 5/20 5.1 % 0.80 [ 0.25, 2.55 ]
Schmitt 1994 15/22 7/20 7.5 % 1.95 [ 1.00, 3.78 ]
Subtotal (95% CI) 169 269 83.9 % 0.88 [ 0.68, 1.13 ]
Total events: 60 (LA-IPAA), 113 (Open-IPAA)
Heterogeneity: Chi2 = 7.53, df = 4 (P = 0.11); I2 =47%
Test for overall effect: Z = 1.02 (P = 0.31)
2 Low-quality trials
Araki 2001 11/21 7/11 9.5 % 0.82 [ 0.45, 1.51 ]
Brown 2001 2/12 2/13 2.0 % 1.08 [ 0.18, 6.53 ]
Hashimoto 2001 7/11 5/13 4.7 % 1.65 [ 0.73, 3.76 ]
Subtotal (95% CI) 44 37 16.1 % 1.10 [ 0.68, 1.77 ]
Total events: 20 (LA-IPAA), 14 (Open-IPAA)
Heterogeneity: Chi2 = 1.83, df = 2 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.70)
Total (95% CI) 213 306 100.0 % 0.91 [ 0.73, 1.14 ]
Total events: 80 (LA-IPAA), 127 (Open-IPAA)
Heterogeneity: Chi2 = 9.73, df = 7 (P = 0.20); I2 =28%
Test for overall effect: Z = 0.80 (P = 0.42)
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Analysis 2.5. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 5 Operative time (minutes).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 5 Operative time (minutes)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 High-quality trials
Berdah 2004 12 402.5 (35.96) 12 305 (42.1) 30.0 % 97.50 [ 66.17, 128.83 ]
Dunker 2001 15 292.3 (39) 17 159.9 (35) 32.1 % 132.40 [ 106.59, 158.21 ]
Subtotal (95% CI) 27 29 62.1 % 116.12 [ 82.00, 150.25 ]
Heterogeneity: Tau2 = 394.55; Chi2 = 2.84, df = 1 (P = 0.09); I2 =65%
Test for overall effect: Z = 6.67 (P < 0.00001)
2 Low-quality trials
Araki 2001 21 215 (141) 11 198 (112) 12.2 % 17.00 [ -72.54, 106.54 ]
Otani 2001 10 377 (58.8) 18 308 (46.9) 25.7 % 69.00 [ 26.60, 111.40 ]
Subtotal (95% CI) 31 29 37.9 % 58.57 [ 17.76, 99.38 ]
Heterogeneity: Tau2 = 74.49; Chi2 = 1.06, df = 1 (P = 0.30); I2 =6%
Test for overall effect: Z = 2.81 (P = 0.0049)
Total (95% CI) 58 58 100.0 % 91.52 [ 53.36, 129.68 ]
Heterogeneity: Tau2 = 1008.13; Chi2 = 11.02, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 4.70 (P < 0.00001)
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Analysis 2.6. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 6 Blood loss (mL).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 6 Blood loss (mL)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Low-quality trials
Araki 2001 21 218 (268) 11 238 (102) 52.7 % -20.00 [ -149.51, 109.51 ]
Otani 2001 10 177 (142) 18 363 (262) 47.3 % -186.00 [ -335.65, -36.35 ]
Total (95% CI) 31 29 100.0 % -98.59 [ -261.04, 63.86 ]
Heterogeneity: Tau2 = 8680.02; Chi2 = 2.70, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.19 (P = 0.23)
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Analysis 2.7. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 7 Time to regular diet (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 7 Time to regular diet (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High-quality trials
Dunker 2001 15 5.6 (1.3) 17 7 (2.2) 98.9 % -1.40 [ -2.64, -0.16 ]
Subtotal (95% CI) 15 17 98.9 % -1.40 [ -2.64, -0.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.22 (P = 0.026)
2 Low-quality trials
Otani 2001 10 10.3 (3.5) 18 19.2 (25.3) 1.1 % -8.90 [ -20.79, 2.99 ]
Subtotal (95% CI) 10 18 1.1 % -8.90 [ -20.79, 2.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
Total (95% CI) 25 35 100.0 % -1.48 [ -2.71, -0.25 ]
Heterogeneity: Chi2 = 1.51, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Chi2 = 1.51, df = 1 (P = 0.22), I2 =34%
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Analysis 2.8. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 8 Hospital stay (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 8 Hospital stay (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High-quality trial
Berdah 2004 12 11.92 (3.68) 12 14.9 (6.3) 15.4 % -2.98 [ -7.11, 1.15 ]
Dunker 2001 15 9.9 (2.4) 17 12.5 (2.7) 84.0 % -2.60 [ -4.37, -0.83 ]
Subtotal (95% CI) 27 29 99.4 % -2.66 [ -4.28, -1.03 ]
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 3.21 (P = 0.0013)
2 Low-quality trial
Araki 2001 21 36.1 (31.4) 11 39.3 (28.3) 0.6 % -3.20 [ -24.65, 18.25 ]
Subtotal (95% CI) 21 11 0.6 % -3.20 [ -24.65, 18.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 48 40 100.0 % -2.66 [ -4.28, -1.04 ]
Heterogeneity: Chi2 = 0.03, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.96), I2 =0.0%
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Analysis 2.9. Comparison 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding
contemporary groups, Outcome 9 Reoperation.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 2 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding contemporary groups
Outcome: 9 Reoperation
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 11.5 % 0.33 [ 0.01, 7.45 ]
Dunker 2001 1/15 1/17 7.2 % 1.13 [ 0.08, 16.59 ]
Larson 2006 3/100 13/200 66.4 % 0.46 [ 0.13, 1.58 ]
Schmitt 1994 1/22 0/20 4.0 % 2.74 [ 0.12, 63.63 ]
Subtotal (95% CI) 149 249 89.1 % 0.60 [ 0.23, 1.57 ]
Total events: 5 (LA-IPAA), 15 (Open-IPAA)
Heterogeneity: Chi2 = 1.42, df = 3 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.04 (P = 0.30)
2 Low-quality trials
Brown 2001 1/12 1/13 7.4 % 1.08 [ 0.08, 15.46 ]
Hashimoto 2001 1/11 0/13 3.5 % 3.50 [ 0.16, 78.19 ]
Subtotal (95% CI) 23 26 10.9 % 1.87 [ 0.27, 13.04 ]
Total events: 2 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: Chi2 = 0.32, df = 1 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
Total (95% CI) 172 275 100.0 % 0.74 [ 0.32, 1.71 ]
Total events: 7 (LA-IPAA), 16 (Open-IPAA)
Heterogeneity: Chi2 = 2.62, df = 5 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.70 (P = 0.48)
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Analysis 3.1. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 1 Procedure specific complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 1 Procedure specific complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Araki 2001 4/21 3/11 44.2 % 0.70 [ 0.19, 2.58 ]
Berdah 2004 0/12 1/12 16.9 % 0.33 [ 0.01, 7.45 ]
Larson 2006 1/100 3/200 22.5 % 0.67 [ 0.07, 6.33 ]
Marcello 2000 1/20 1/20 11.2 % 1.00 [ 0.07, 14.90 ]
Subtotal (95% CI) 153 243 94.8 % 0.66 [ 0.24, 1.79 ]
Total events: 6 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 0.28, df = 3 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.81 (P = 0.42)
2 Low-quality trials
Hashimoto 2001 1/11 0/13 5.2 % 3.50 [ 0.16, 78.19 ]
Subtotal (95% CI) 11 13 5.2 % 3.50 [ 0.16, 78.19 ]
Total events: 1 (LA-IPAA), 0 (Open-IPAA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
Total (95% CI) 164 256 100.0 % 0.81 [ 0.32, 2.02 ]
Total events: 7 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 1.27, df = 4 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
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Analysis 3.2. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 2 Severe postoperative complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 2 Severe postoperative complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 1/12 1/12 6.6 % 1.00 [ 0.07, 14.21 ]
Brown 2001 1/12 1/13 6.3 % 1.08 [ 0.08, 15.46 ]
Larson 2006 3/100 17/200 74.6 % 0.35 [ 0.11, 1.18 ]
Subtotal (95% CI) 124 225 87.5 % 0.45 [ 0.17, 1.23 ]
Total events: 5 (LA-IPAA), 19 (Open-IPAA)
Heterogeneity: Chi2 = 0.92, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
2 Low-quality trials
Hashimoto 2001 0/11 1/13 9.1 % 0.39 [ 0.02, 8.69 ]
Schmitt 1994 3/22 0/20 3.4 % 6.39 [ 0.35, 116.57 ]
Subtotal (95% CI) 33 33 12.5 % 2.03 [ 0.36, 11.37 ]
Total events: 3 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: Chi2 = 1.69, df = 1 (P = 0.19); I2 =41%
Test for overall effect: Z = 0.81 (P = 0.42)
Total (95% CI) 157 258 100.0 % 0.65 [ 0.29, 1.48 ]
Total events: 8 (LA-IPAA), 20 (Open-IPAA)
Heterogeneity: Chi2 = 3.72, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
0.01 0.1 1 10 100
Favours LA-IPAA Favours Open-IPAA
53Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.3. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 3 Minor complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 3 Minor complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Araki 2001 7/21 4/11 8.3 % 0.92 [ 0.34, 2.46 ]
Berdah 2004 3/12 1/12 1.6 % 3.00 [ 0.36, 24.92 ]
Brown 2001 1/12 0/13 0.8 % 3.23 [ 0.14, 72.46 ]
Larson 2006 26/100 64/200 67.7 % 0.81 [ 0.55, 1.20 ]
Marcello 2000 3/20 4/20 6.3 % 0.75 [ 0.19, 2.93 ]
Subtotal (95% CI) 165 256 84.7 % 0.88 [ 0.63, 1.24 ]
Total events: 40 (LA-IPAA), 73 (Open-IPAA)
Heterogeneity: Chi2 = 2.18, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.73 (P = 0.46)
2 Low-quality trials
Dunker 2001 1/15 3/17 4.5 % 0.38 [ 0.04, 3.26 ]
Hashimoto 2001 6/11 4/13 5.8 % 1.77 [ 0.67, 4.71 ]
Schmitt 1994 12/22 3/20 5.0 % 3.64 [ 1.20, 11.04 ]
Subtotal (95% CI) 48 50 15.3 % 1.97 [ 1.01, 3.84 ]
Total events: 19 (LA-IPAA), 10 (Open-IPAA)
Heterogeneity: Chi2 = 3.47, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 2.00 (P = 0.045)
Total (95% CI) 213 306 100.0 % 1.05 [ 0.78, 1.41 ]
Total events: 59 (LA-IPAA), 83 (Open-IPAA)
Heterogeneity: Chi2 = 10.20, df = 7 (P = 0.18); I2 =31%
Test for overall effect: Z = 0.31 (P = 0.76)
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Analysis 3.4. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 4 Total Complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 4 Total Complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Araki 2001 11/21 7/11 9.5 % 0.82 [ 0.45, 1.51 ]
Berdah 2004 4/12 3/12 3.1 % 1.33 [ 0.38, 4.72 ]
Brown 2001 2/12 2/13 2.0 % 1.08 [ 0.18, 6.53 ]
Larson 2006 36/100 95/200 65.2 % 0.76 [ 0.56, 1.02 ]
Marcello 2000 4/20 5/20 5.1 % 0.80 [ 0.25, 2.55 ]
Subtotal (95% CI) 165 256 84.8 % 0.80 [ 0.62, 1.03 ]
Total events: 57 (LA-IPAA), 112 (Open-IPAA)
Heterogeneity: Chi2 = 0.87, df = 4 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.74 (P = 0.082)
2 Low-quality trials
Dunker 2001 1/15 3/17 2.9 % 0.38 [ 0.04, 3.26 ]
Hashimoto 2001 7/11 5/13 4.7 % 1.65 [ 0.73, 3.76 ]
Schmitt 1994 15/22 7/20 7.5 % 1.95 [ 1.00, 3.78 ]
Subtotal (95% CI) 48 50 15.2 % 1.56 [ 0.95, 2.56 ]
Total events: 23 (LA-IPAA), 15 (Open-IPAA)
Heterogeneity: Chi2 = 2.12, df = 2 (P = 0.35); I2 =6%
Test for overall effect: Z = 1.75 (P = 0.080)
Total (95% CI) 213 306 100.0 % 0.91 [ 0.73, 1.14 ]
Total events: 80 (LA-IPAA), 127 (Open-IPAA)
Heterogeneity: Chi2 = 9.73, df = 7 (P = 0.20); I2 =28%
Test for overall effect: Z = 0.80 (P = 0.42)
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Analysis 3.5. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 5 Operative time (minutes).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 5 Operative time (minutes)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 High-quality trials
Araki 2001 21 215 (141) 11 198 (112) 12.2 % 17.00 [ -72.54, 106.54 ]
Berdah 2004 12 402.5 (35.96) 12 305 (42.1) 30.0 % 97.50 [ 66.17, 128.83 ]
Subtotal (95% CI) 33 23 42.2 % 68.63 [ -7.05, 144.30 ]
Heterogeneity: Tau2 = 2068.86; Chi2 = 2.77, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 1.78 (P = 0.075)
2 Low-quality trials
Dunker 2001 15 292.3 (39) 17 159.9 (35) 32.1 % 132.40 [ 106.59, 158.21 ]
Otani 2001 10 377 (58.8) 18 308 (46.9) 25.7 % 69.00 [ 26.60, 111.40 ]
Subtotal (95% CI) 25 35 57.8 % 103.02 [ 41.06, 164.99 ]
Heterogeneity: Tau2 = 1689.08; Chi2 = 6.27, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 3.26 (P = 0.0011)
Total (95% CI) 58 58 100.0 % 91.52 [ 53.36, 129.68 ]
Heterogeneity: Tau2 = 1008.13; Chi2 = 11.02, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 4.70 (P < 0.00001)
-200 -100 0 100 200
Favours LA-IPAA Favours open-IPAA
56Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.6. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 6 Blood loss (mL).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 6 Blood loss (mL)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 High-quality trials
Araki 2001 21 218 (268) 11 238 (102) 52.7 % -20.00 [ -149.51, 109.51 ]
Subtotal (95% CI) 21 11 52.7 % -20.00 [ -149.51, 109.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
2 Low-quality trials
Otani 2001 10 177 (142) 18 363 (262) 47.3 % -186.00 [ -335.65, -36.35 ]
Subtotal (95% CI) 10 18 47.3 % -186.00 [ -335.65, -36.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.44 (P = 0.015)
Total (95% CI) 31 29 100.0 % -98.59 [ -261.04, 63.86 ]
Heterogeneity: Tau2 = 8680.02; Chi2 = 2.70, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.19 (P = 0.23)
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Analysis 3.7. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 7 Time to regular diet (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 7 Time to regular diet (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-quality trials
Dunker 2001 15 5.6 (1.3) 17 7 (2.2) 98.9 % -1.40 [ -2.64, -0.16 ]
Otani 2001 10 10.3 (3.5) 18 19.2 (25.3) 1.1 % -8.90 [ -20.79, 2.99 ]
Total (95% CI) 25 35 100.0 % -1.48 [ -2.71, -0.25 ]
Heterogeneity: Chi2 = 1.51, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Not applicable
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Analysis 3.8. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 8 Hospital stay (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 8 Hospital stay (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High-quality trial
Araki 2001 21 36.1 (31.4) 11 39.3 (28.3) 0.6 % -3.20 [ -24.65, 18.25 ]
Berdah 2004 12 11.92 (3.68) 12 14.9 (6.3) 15.4 % -2.98 [ -7.11, 1.15 ]
Subtotal (95% CI) 33 23 16.0 % -2.99 [ -7.04, 1.07 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.44 (P = 0.15)
2 Low-quality trial
Dunker 2001 15 9.9 (2.4) 17 12.5 (2.7) 84.0 % -2.60 [ -4.37, -0.83 ]
Subtotal (95% CI) 15 17 84.0 % -2.60 [ -4.37, -0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.88 (P = 0.0039)
Total (95% CI) 48 40 100.0 % -2.66 [ -4.28, -1.04 ]
Heterogeneity: Chi2 = 0.03, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.86), I2 =0.0%
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Analysis 3.9. Comparison 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline
equivalence, Outcome 9 Reoperation.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 3 LA-IPAA vs Open-IPAA - high-quality and low-quality trials regarding baseline equivalence
Outcome: 9 Reoperation
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 11.5 % 0.33 [ 0.01, 7.45 ]
Brown 2001 1/12 1/13 7.4 % 1.08 [ 0.08, 15.46 ]
Larson 2006 3/100 13/200 66.4 % 0.46 [ 0.13, 1.58 ]
Subtotal (95% CI) 124 225 85.3 % 0.50 [ 0.18, 1.41 ]
Total events: 4 (LA-IPAA), 15 (Open-IPAA)
Heterogeneity: Chi2 = 0.41, df = 2 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 1.31 (P = 0.19)
2 Low-quality trials
Dunker 2001 1/15 1/17 7.2 % 1.13 [ 0.08, 16.59 ]
Hashimoto 2001 1/11 0/13 3.5 % 3.50 [ 0.16, 78.19 ]
Schmitt 1994 1/22 0/20 4.0 % 2.74 [ 0.12, 63.63 ]
Subtotal (95% CI) 48 50 14.7 % 2.14 [ 0.41, 11.25 ]
Total events: 3 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: Chi2 = 0.34, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 0.90 (P = 0.37)
Total (95% CI) 172 275 100.0 % 0.74 [ 0.32, 1.71 ]
Total events: 7 (LA-IPAA), 16 (Open-IPAA)
Heterogeneity: Chi2 = 2.62, df = 5 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.70 (P = 0.48)
0.001 0.01 0.1 1 10 100 1000
Favours LA-IPAA Favours Open-IPAA
60Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.1. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 1
Procedure specific complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 1 Procedure specific complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 16.9 % 0.33 [ 0.01, 7.45 ]
Marcello 2000 1/20 1/20 11.2 % 1.00 [ 0.07, 14.90 ]
Subtotal (95% CI) 32 32 28.1 % 0.60 [ 0.08, 4.30 ]
Total events: 1 (LA-IPAA), 2 (Open-IPAA)
Heterogeneity: Chi2 = 0.27, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
2 Low-quality trials
Araki 2001 4/21 3/11 44.2 % 0.70 [ 0.19, 2.58 ]
Hashimoto 2001 1/11 0/13 5.2 % 3.50 [ 0.16, 78.19 ]
Larson 2006 1/100 3/200 22.5 % 0.67 [ 0.07, 6.33 ]
Subtotal (95% CI) 132 224 71.9 % 0.89 [ 0.32, 2.51 ]
Total events: 6 (LA-IPAA), 6 (Open-IPAA)
Heterogeneity: Chi2 = 0.94, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.83)
Total (95% CI) 164 256 100.0 % 0.81 [ 0.32, 2.02 ]
Total events: 7 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 1.27, df = 4 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
0.01 0.1 1 10 100
Favours LA-IPAA Favours Open-IPAA
61Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.2. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 2
Severe postoperative complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 2 Severe postoperative complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 1/12 1/12 6.6 % 1.00 [ 0.07, 14.21 ]
Subtotal (95% CI) 12 12 6.6 % 1.00 [ 0.07, 14.21 ]
Total events: 1 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Low-quality trials
Brown 2001 1/12 1/13 6.3 % 1.08 [ 0.08, 15.46 ]
Hashimoto 2001 0/11 1/13 9.1 % 0.39 [ 0.02, 8.69 ]
Larson 2006 3/100 17/200 74.6 % 0.35 [ 0.11, 1.18 ]
Schmitt 1994 3/22 0/20 3.4 % 6.39 [ 0.35, 116.57 ]
Subtotal (95% CI) 145 246 93.4 % 0.63 [ 0.26, 1.49 ]
Total events: 7 (LA-IPAA), 19 (Open-IPAA)
Heterogeneity: Chi2 = 3.59, df = 3 (P = 0.31); I2 =16%
Test for overall effect: Z = 1.05 (P = 0.29)
Total (95% CI) 157 258 100.0 % 0.65 [ 0.29, 1.48 ]
Total events: 8 (LA-IPAA), 20 (Open-IPAA)
Heterogeneity: Chi2 = 3.72, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
0.01 0.1 1 10 100
Favours LA-IPAA Favours Open-IPAA
62Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.3. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 3
Minor complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 3 Minor complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 3/12 1/12 1.6 % 3.00 [ 0.36, 24.92 ]
Marcello 2000 3/20 4/20 6.3 % 0.75 [ 0.19, 2.93 ]
Subtotal (95% CI) 32 32 7.9 % 1.20 [ 0.40, 3.57 ]
Total events: 6 (LA-IPAA), 5 (Open-IPAA)
Heterogeneity: Chi2 = 1.18, df = 1 (P = 0.28); I2 =15%
Test for overall effect: Z = 0.33 (P = 0.74)
2 Low-quality trials
Araki 2001 7/21 4/11 8.3 % 0.92 [ 0.34, 2.46 ]
Brown 2001 1/12 0/13 0.8 % 3.23 [ 0.14, 72.46 ]
Dunker 2001 1/15 3/17 4.5 % 0.38 [ 0.04, 3.26 ]
Hashimoto 2001 6/11 4/13 5.8 % 1.77 [ 0.67, 4.71 ]
Larson 2006 26/100 64/200 67.7 % 0.81 [ 0.55, 1.20 ]
Schmitt 1994 12/22 3/20 5.0 % 3.64 [ 1.20, 11.04 ]
Subtotal (95% CI) 181 274 92.1 % 1.03 [ 0.76, 1.41 ]
Total events: 53 (LA-IPAA), 78 (Open-IPAA)
Heterogeneity: Chi2 = 8.99, df = 5 (P = 0.11); I2 =44%
Test for overall effect: Z = 0.21 (P = 0.83)
Total (95% CI) 213 306 100.0 % 1.05 [ 0.78, 1.41 ]
Total events: 59 (LA-IPAA), 83 (Open-IPAA)
Heterogeneity: Chi2 = 10.20, df = 7 (P = 0.18); I2 =31%
Test for overall effect: Z = 0.31 (P = 0.76)
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Analysis 4.4. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 4
Total Complications.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 4 Total Complications
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 4/12 3/12 3.1 % 1.33 [ 0.38, 4.72 ]
Marcello 2000 4/20 5/20 5.1 % 0.80 [ 0.25, 2.55 ]
Subtotal (95% CI) 32 32 8.2 % 1.00 [ 0.43, 2.34 ]
Total events: 8 (LA-IPAA), 8 (Open-IPAA)
Heterogeneity: Chi2 = 0.34, df = 1 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.0 (P = 1.0)
2 Low-quality trials
Araki 2001 11/21 7/11 9.5 % 0.82 [ 0.45, 1.51 ]
Brown 2001 2/12 2/13 2.0 % 1.08 [ 0.18, 6.53 ]
Dunker 2001 1/15 3/17 2.9 % 0.38 [ 0.04, 3.26 ]
Hashimoto 2001 7/11 5/13 4.7 % 1.65 [ 0.73, 3.76 ]
Larson 2006 36/100 95/200 65.2 % 0.76 [ 0.56, 1.02 ]
Schmitt 1994 15/22 7/20 7.5 % 1.95 [ 1.00, 3.78 ]
Subtotal (95% CI) 181 274 91.8 % 0.90 [ 0.72, 1.14 ]
Total events: 72 (LA-IPAA), 119 (Open-IPAA)
Heterogeneity: Chi2 = 9.35, df = 5 (P = 0.10); I2 =47%
Test for overall effect: Z = 0.85 (P = 0.40)
Total (95% CI) 213 306 100.0 % 0.91 [ 0.73, 1.14 ]
Total events: 80 (LA-IPAA), 127 (Open-IPAA)
Heterogeneity: Chi2 = 9.73, df = 7 (P = 0.20); I2 =28%
Test for overall effect: Z = 0.80 (P = 0.42)
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Analysis 4.5. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 5
Operative time (minutes).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 5 Operative time (minutes)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 High-quality trials
Berdah 2004 12 402.5 (35.96) 12 305 (42.1) 30.0 % 97.50 [ 66.17, 128.83 ]
Subtotal (95% CI) 12 12 30.0 % 97.50 [ 66.17, 128.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.10 (P < 0.00001)
2 Low-quality trials
Araki 2001 21 215 (141) 11 198 (112) 12.2 % 17.00 [ -72.54, 106.54 ]
Dunker 2001 15 292.3 (39) 17 159.9 (35) 32.1 % 132.40 [ 106.59, 158.21 ]
Otani 2001 10 377 (58.8) 18 308 (46.9) 25.7 % 69.00 [ 26.60, 111.40 ]
Subtotal (95% CI) 46 46 70.0 % 83.03 [ 21.45, 144.61 ]
Heterogeneity: Tau2 = 2244.88; Chi2 = 10.63, df = 2 (P = 0.005); I2 =81%
Test for overall effect: Z = 2.64 (P = 0.0082)
Total (95% CI) 58 58 100.0 % 91.52 [ 53.36, 129.68 ]
Heterogeneity: Tau2 = 1008.13; Chi2 = 11.02, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 4.70 (P < 0.00001)
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Analysis 4.6. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 6
Blood loss (mL).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 6 Blood loss (mL)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Low-quality trials
Araki 2001 21 218 (268) 11 238 (102) 52.7 % -20.00 [ -149.51, 109.51 ]
Otani 2001 10 177 (142) 18 363 (262) 47.3 % -186.00 [ -335.65, -36.35 ]
Total (95% CI) 31 29 100.0 % -98.59 [ -261.04, 63.86 ]
Heterogeneity: Tau2 = 8680.02; Chi2 = 2.70, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.19 (P = 0.23)
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Analysis 4.7. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 7
Time to regular diet (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 7 Time to regular diet (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Low-quality trials
Dunker 2001 15 5.6 (1.3) 17 7 (2.2) 98.9 % -1.40 [ -2.64, -0.16 ]
Otani 2001 10 10.3 (3.5) 18 19.2 (25.3) 1.1 % -8.90 [ -20.79, 2.99 ]
Total (95% CI) 25 35 100.0 % -1.48 [ -2.71, -0.25 ]
Heterogeneity: Chi2 = 1.51, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Not applicable
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Analysis 4.8. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 8
Hospital stay (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 8 Hospital stay (days)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High-quality trial
Berdah 2004 12 11.92 (3.68) 12 14.9 (6.3) 15.4 % -2.98 [ -7.11, 1.15 ]
Subtotal (95% CI) 12 12 15.4 % -2.98 [ -7.11, 1.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.41 (P = 0.16)
2 Low-quality trial
Araki 2001 21 36.1 (31.4) 11 39.3 (28.3) 0.6 % -3.20 [ -24.65, 18.25 ]
Dunker 2001 15 9.9 (2.4) 17 12.5 (2.7) 84.0 % -2.60 [ -4.37, -0.83 ]
Subtotal (95% CI) 36 28 84.6 % -2.60 [ -4.37, -0.84 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 2.90 (P = 0.0038)
Total (95% CI) 48 40 100.0 % -2.66 [ -4.28, -1.04 ]
Heterogeneity: Chi2 = 0.03, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
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Analysis 4.9. Comparison 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials, Outcome 9
Reoperation.
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 4 LA-IPAA vs Open-IPAA - highest-quality trials versus other trials
Outcome: 9 Reoperation
Study or subgroup LA-IPAA Open-IPAA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Berdah 2004 0/12 1/12 11.5 % 0.33 [ 0.01, 7.45 ]
Subtotal (95% CI) 12 12 11.5 % 0.33 [ 0.01, 7.45 ]
Total events: 0 (LA-IPAA), 1 (Open-IPAA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
2 Low-quality trials
Brown 2001 1/12 1/13 7.4 % 1.08 [ 0.08, 15.46 ]
Dunker 2001 1/15 1/17 7.2 % 1.13 [ 0.08, 16.59 ]
Hashimoto 2001 1/11 0/13 3.5 % 3.50 [ 0.16, 78.19 ]
Larson 2006 3/100 13/200 66.4 % 0.46 [ 0.13, 1.58 ]
Schmitt 1994 1/22 0/20 4.0 % 2.74 [ 0.12, 63.63 ]
Subtotal (95% CI) 160 263 88.5 % 0.79 [ 0.33, 1.91 ]
Total events: 7 (LA-IPAA), 15 (Open-IPAA)
Heterogeneity: Chi2 = 2.34, df = 4 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.52 (P = 0.60)
Total (95% CI) 172 275 100.0 % 0.74 [ 0.32, 1.71 ]
Total events: 7 (LA-IPAA), 16 (Open-IPAA)
Heterogeneity: Chi2 = 2.62, df = 5 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.70 (P = 0.48)
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Analysis 5.1. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 1 Sensitivity analysis 1:
Imputing means and standard deviations in operative time (minutes).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 1 Sensitivity analysis 1: Imputing means and standard deviations in operative time (minutes)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Araki 2001 21 215 (141) 11 198 (112) 4.6 % 17.00 [ -72.54, 106.54 ]
Berdah 2004 12 402.5 (35.96) 12 305 (42.1) 12.4 % 97.50 [ 66.17, 128.83 ]
Brown 2001 12 161.25 (39.51) 13 123.75 (21.76) 13.5 % 37.50 [ 12.21, 62.79 ]
Dunker 2001 15 292.3 (39) 17 159.9 (35) 13.4 % 132.40 [ 106.59, 158.21 ]
Hashimoto 2001 11 500 (62.55) 13 431 (110.97) 6.3 % 69.00 [ -1.75, 139.75 ]
Larson 2006 100 333 (68.17) 200 230 (47.83) 15.2 % 103.00 [ 88.08, 117.92 ]
Marcello 2000 20 330 (75) 20 232.5 (30) 11.6 % 97.50 [ 62.10, 132.90 ]
Otani 2001 10 377 (58.8) 18 308 (46.9) 10.3 % 69.00 [ 26.60, 111.40 ]
Schmitt 1994 22 232.5 (52.5) 20 165 (45) 12.7 % 67.50 [ 38.00, 97.00 ]
Total (95% CI) 223 324 100.0 % 82.66 [ 59.99, 105.33 ]
Heterogeneity: Tau2 = 824.97; Chi2 = 36.29, df = 8 (P = 0.00002); I2 =78%
Test for overall effect: Z = 7.15 (P < 0.00001)
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Analysis 5.2. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 2 Sensitivity analysis 2:
Imputing means and standard deviations in blood loss (mL).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 2 Sensitivity analysis 2: Imputing means and standard deviations in blood loss (mL)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Araki 2001 21 218 (268) 11 238 (102) 31.7 % -20.00 [ -149.51, 109.51 ]
Hashimoto 2001 11 442.25 (271.68) 13 693 (369.01) 11.9 % -250.75 [ -507.68, 6.18 ]
Marcello 2000 20 325 (150) 20 500 (275) 29.7 % -175.00 [ -312.28, -37.72 ]
Otani 2001 10 177 (142) 18 363 (262) 26.7 % -186.00 [ -335.65, -36.35 ]
Total (95% CI) 62 62 100.0 % -137.75 [ -234.64, -40.86 ]
Heterogeneity: Tau2 = 3331.90; Chi2 = 4.57, df = 3 (P = 0.21); I2 =34%
Test for overall effect: Z = 2.79 (P = 0.0053)
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Analysis 5.3. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 3 Sensitivity analysis 3:
Imputing means and standard deviations in time to bowel movement (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 3 Sensitivity analysis 3: Imputing means and standard deviations in time to bowel movement (days)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Araki 2001 21 1.7 (1.5) 11 5.4 (4.9) 16.9 % -3.70 [ -6.67, -0.73 ]
Larson 2006 100 2 (1) 200 3 (0.83) 49.9 % -1.00 [ -1.23, -0.77 ]
Marcello 2000 20 3 (1.75) 20 5.5 (3) 33.2 % -2.50 [ -4.02, -0.98 ]
Total (95% CI) 141 231 100.0 % -1.96 [ -3.45, -0.46 ]
Heterogeneity: Tau2 = 1.16; Chi2 = 6.74, df = 2 (P = 0.03); I2 =70%
Test for overall effect: Z = 2.56 (P = 0.011)
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Analysis 5.4. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 4 Sensitivity analysis 4:
Imputing means and standard deviations in time to regular diet (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 4 Sensitivity analysis 4: Imputing means and standard deviations in time to regular diet (days)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brown 2001 12 5 (2.04) 13 6.5 (4.29) 7.7 % -1.50 [ -4.10, 1.10 ]
Dunker 2001 15 5.6 (1.3) 17 7 (2.2) 22.9 % -1.40 [ -2.64, -0.16 ]
Hashimoto 2001 11 3.8 (1.16) 13 4.4 (1.44) 27.4 % -0.60 [ -1.64, 0.44 ]
Larson 2006 100 3 (1.67) 200 5 (3.3) 41.6 % -2.00 [ -2.56, -1.44 ]
Otani 2001 10 10.3 (3.5) 18 19.2 (25.3) 0.4 % -8.90 [ -20.79, 2.99 ]
Total (95% CI) 148 261 100.0 % -1.47 [ -2.25, -0.69 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 7.00, df = 4 (P = 0.14); I2 =43%
Test for overall effect: Z = 3.68 (P = 0.00023)
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Analysis 5.5. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 5 Sensitivity analysis 5:
Imputing means and standard deviations in hospital stay (days).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 5 Sensitivity analysis 5: Imputing means and standard deviations in hospital stay (days)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Araki 2001 21 36.1 (31.4) 11 39.3 (28.3) 0.2 % -3.20 [ -24.65, 18.25 ]
Berdah 2004 12 11.92 (3.68) 12 14.9 (6.3) 5.0 % -2.98 [ -7.11, 1.15 ]
Brown 2001 12 8.75 (3.54) 13 8.5 (3.33) 9.9 % 0.25 [ -2.45, 2.95 ]
Dunker 2001 15 9.9 (2.4) 17 12.5 (2.7) 16.8 % -2.60 [ -4.37, -0.83 ]
Hashimoto 2001 11 24.3 (6.64) 13 32.4 (8.97) 2.4 % -8.10 [ -14.36, -1.84 ]
Larson 2006 100 4 (3.17) 200 7 (4.67) 27.4 % -3.00 [ -3.90, -2.10 ]
Marcello 2000 20 8 (2.5) 20 9.75 (2.75) 18.2 % -1.75 [ -3.38, -0.12 ]
Schmitt 1994 22 9.35 (1.5) 20 10.45 (3) 20.1 % -1.10 [ -2.56, 0.36 ]
Total (95% CI) 213 306 100.0 % -2.12 [ -3.12, -1.12 ]
Heterogeneity: Tau2 = 0.74; Chi2 = 12.33, df = 7 (P = 0.09); I2 =43%
Test for overall effect: Z = 4.15 (P = 0.000033)
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Analysis 5.6. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 6 Sensitivity analysis 6:
Imputing means and standard deviations in incision length (cm).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 6 Sensitivity analysis 6: Imputing means and standard deviations in incision length (cm)





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Brown 2001 12 9.5 (3.23) 13 16.5 (3.75) 47.7 % -7.00 [ -9.74, -4.26 ]
Dunker 2001 15 15.4 (3.9) 17 23.9 (3.6) 52.3 % -8.50 [ -11.11, -5.89 ]
Total (95% CI) 27 30 100.0 % -7.79 [ -9.68, -5.90 ]
Heterogeneity: Chi2 = 0.60, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 8.07 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 5.7. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 7 Sensitivity analysis 8:
Imputing means and standard deviations in defecation frequency day (times/day).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 7 Sensitivity analysis 8: Imputing means and standard deviations in defecation frequency day (times/day)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Dunker 2001 15 5.7 (1.3) 17 6.3 (2) 50.7 % -0.60 [ -1.76, 0.56 ]
Larson 2005 33 7 (2.75) 33 6 (2.25) 49.3 % 1.00 [ -0.21, 2.21 ]
Total (95% CI) 48 50 100.0 % 0.19 [ -1.38, 1.76 ]
Heterogeneity: Tau2 = 0.91; Chi2 = 3.50, df = 1 (P = 0.06); I2 =71%
Test for overall effect: Z = 0.24 (P = 0.81)
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Analysis 5.8. Comparison 5 LA-IPAA vs Open-IPAA - sensitivity analsyses, Outcome 8 Sensitivity analysis 9:
Imputing means and standard deviations in defecation frequency night (times/night).
Review: Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis
Comparison: 5 LA-IPAA vs Open-IPAA - sensitivity analsyses
Outcome: 8 Sensitivity analysis 9: Imputing means and standard deviations in defecation frequency night (times/night)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Dunker 2001 15 1 (0.7) 17 1.3 (0.7) 48.6 % -0.30 [ -0.79, 0.19 ]
Larson 2005 33 1 (1) 33 2 (0.75) 51.4 % -1.00 [ -1.43, -0.57 ]
Total (95% CI) 48 50 100.0 % -0.66 [ -1.35, 0.03 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 4.50, df = 1 (P = 0.03); I2 =78%
Test for overall effect: Z = 1.89 (P = 0.059)
-4 -2 0 2 4
Favours LA-IPAA Favours Open-IPAA
A D D I T I O N A L T A B L E S
Table 1. Search strategies
Database Search strategy Time span of search Hits
The Cochrane Library ((ulcerative colitisORcolitis ul-




sis OR familial polyposis OR
adenomatous polyposis coliOR
polyposis coli OR FAP))
AND
(surgery OR surgical OR sur-
gically OR laparoscopy OR
laparoscopic OR laparoscopi-
cally OR ileo pouch OR ileal
pouch OR pouch-anal anasto-
mosis OR pelvic pouch OR
“IPAA” OR restorative proc-
tocolectomy OR “RPC” OR
“RP”ORcolorectal surgeryOR
colonic pouch)
Issue 1, 2007 649
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Table 1. Search strategies (Continued)
Pubmed ((ulcerative colitis [TIAB] OR
colitis ulcerosa [TIAB] OR
“uc” [TIAB] OR “ibd” [TIAB]
OR inflammatory bowel dis-
ease [TIAB] OR Colitis, Ulcer-




sis [TIAB] OR familial polypo-
sis [TIAB] OR “FAP”[TIAB]
ORadenomatous polyposis coli
[TIAB] OR polyposis coli




[MH] OR surgery [Subhead-
ing] OR surgical[TIAB] OR
surgically[TIAB]
OR laparoscopy[TIAB] OR la-
paroscopy [MH] OR laparo-
scopic [TIAB] OR laparoscopi-
cally [TIAB]
OR ileo pouch[TIAB] OR
ileal pouch [TIAB] OR pelvic
pouch[TIAB] OR pouch-anal
anastomosis [TIAB] OR
“IPAA” OR restorative procto-
colectomy[TIAB] OR colorec-
tal surgery [MH] OR surgi-
cal procedures, operative [MH]
OR Surgical Procedures, Minor
[MeSH] OR proctocolectomy,




[pt] OR Controlled Clinical
Trial [pt] OR Randomized
Controlled Trials [mh] OR
Random Allocation [mh] OR
double-blind method [mh] OR
single-blind method [mh] OR
clinical trial [pt] OR clinical
trials [mh] OR (“clinical trial”
[tw]) OR ((singl* [tw] OR
1990 - 19 April 2007 4455
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Table 1. Search strategies (Continued)
doubl* [tw] OR trebl* [tw] OR
tripl* [tw]) AND (mask* [tw]
OR blind* [tw])) OR ( place-
bos [mh]OR placebo* [tw] OR
random* [tw] OR research de-
sign [mh:no exp] OR compar-
ative study [publication type]
OR evaluation studies [mh]
OR follow-up studies [mh] OR
prospective studies [mh] OR
control* [tw] OR prospectiv*
[tw] OR volunteer* [tw]) NOT
(animals [mh] NOT human
[mh]))
Embase Search strategy will be con-
ducted through the advanced
search feature of EMBASE,
with the next options tagged
on:
-Map to preferred terminology





(’colitis ulcerosa’:ti,ab OR ’ul-
cerative colitis’:ti,ab OR ’uc’:ti,
ab OR ’ibd’:ti,ab OR ’inflam-
matory bowel disease’:ti,ab OR





ti,ab OR ’familial polyposis’:ti,
ab OR ’FAP’:ti,ab OR ’polypo-
sis coli’:ti,ab OR ’adenomatous










1990 - 19 April 2007 6890
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Table 1. Search strategies (Continued)
exp OR “ileo pouch”:ti,ab OR
“ileal pouch”:ti,ab OR “pelvic
pouch”:ti,ab OR “pouch-anal
anastomosis”:ti,ab OR “IPAA”:
ti,ab OR “restorative procto-
colectomy”:ti,ab OR “colorec-
tal surgery”/exp OR “surgical
procedures, operative”/exp OR
“proctocolectomy, restorative”/




OR “controlled clinical trial”/
exp OR “randomised con-
trolled trials”/exp OR “random
allocation”/exp OR “double-
blind method”/exp OR “single-
blind method”/exp OR “clin-
ical trials”/exp OR “clinical
trial”:ti,ab OR Random* :ti,
ab OR “comparative studies”/
exp OR “evaluation studies”/
expOR“follow-up studies”/exp
OR “prospective studies”/exp
OR control* :ti,abOR prospec-
tiv* :ti,ab OR volunteer* :ti,ab)
ISI Web of Knowledge #1 (ulcerative colitis OR colitis
ulcerosa OR uc OR ibd OR in-
flammatory bowel disease)
#2 (familial adenomatous poly-
posis OR familial polyposis OR
adenomatous polyposis coliOR
polyposis coli OR FAP)
#3 (surgery OR surgical OR
surgically OR laparoscopy OR
laparoscopic OR laparoscopi-
cally OR ileo pouch OR ileal
pouch OR pouch-anal anasto-
mosis OR pelvic pouch OR
IPAA OR restorative procto-
colectomy OR RPC OR col-
orectal surgery OR colonic
pouch)
#4 (randomised controlled trial
OR controlled clinical trial
OR randomised controlled tri-
als OR random allocation OR
1990 - 19 April 2007 1573
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Table 1. Search strategies (Continued)
double-blind method OR sin-
gle-blind method OR clini-
cal trial OR clinical trials OR
clinical trial OR ((singl* OR
doubl* OR trebl* OR tripl* )
AND (mask* OR blind* )) OR
placebos OR placebo* OR ran-
dom* OR comparative study
OR evaluation stud* OR fol-
low-up stud* OR prospective
stud*OR control*ORprospec-
tiv* OR volunteer*)
#5 ((#1 OR #2) AND #3 AND
#4)
The Cochrane IBD/FBD
Group Specialized Trial Regis-
ter (Non Medline Records)
Full manual search. April 2007 930
Webcasts of the Annual Meet-
ings of the ASCRS
Full manual search. All online available web casts
(1997 - 2006)
Not applicable.
Table 2. Modified Methodological Index for Non-Randomised Studies (MINORS)
Item*
1. Inclusion of consecutive patients: all patients potentially fit for inclusion (satisfying the criteria for inclusion) have been included
in the study during the study period (no exclusion or details about the reasons for exclusion)
2. Prospective collection of data: data were collected according to a protocol established before the beginning of the study
3. Unbiased assessment of the study endpoint: blind evaluation of objective endpoints and double-blind evaluation of subjective
endpoints. Otherwise the reasons for not blinding should be stated
4. Follow-up period appropriate to the aim of the study: the follow-up should be sufficiently long to allow the assessment of the main
endpoint and possible adverse events
5. Loss to follow up less then 5%ˆ: all patients should be included in the follow up. Otherwise, the proportion lost to follow up
should not exceed the proportion experiencing the major endpoint; or if the numbers and reasons for dropouts and withdrawals in
all intervention groups were described
6. An adequate control group: having a gold standard diagnostic test or therapeutic intervention recognized as the optimal intervention
according to the available published data
7. Contemporary groups: control and studied group should be managed during the same time period (no historical comparison)
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Table 2. Modified Methodological Index for Non-Randomised Studies (MINORS) (Continued)
8. Baseline equivalence of groups **: the groups should be similar regarding the criteria other than the studied endpoints, i.e. absence
of confounding factors that could bias the interpretation of the results
* Items were scored ’adequate’ if condition was satisfied, ’inadequate’ if condition was not satisfied and ’unclear’ if information regarding
item was not reported.
ˆ Measured at time of discharge, since most trials only followed patients until discharge.
** In this review baselines of the two groups should be equivalent regarding age, gender, BMI and distribution of diagnoses (UC/FAP).
Table 3. Methodological assessment of included studies

















Araki 2001 A U I A A A I A
Berdah
2004
A A I A A A A A
Brown 2001 A I I A A A I A
Dunker
2001
A I I A A A A I
Hashimoto
2001
A I I A A A I I
Larson 2005 A A I A A A A A
Larson 2006 A I I A A A A A
Maartense
2004a
A A I A A A A A
Marcello
2000
A A I A A A A A
Otani 2001 A U I A A A U I
Schmitt
1994
A A I A A A A I
A: Adequate; I: Inadequate; U: Unclear
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Table 4. Characteristics of studies included in the meta-analysis











Araki 2001 21/11 R, NR - D/C 0 0 -
Berdah 2004 12/12 P, NR 1,2,3,4 > 3 years 0 0 3/12 (25%)
Brown 2001 12/13 R, NR - D/C 0 0 0/12 (0%)
Dunker 2001 15/17 R, NR 4,5,8 Mean 16 month 0 0 0/15 (0%)
Hashimoto
2001
11/13 R, NR - D/C 0 0 0/11 (0%)
Larson 2005 33/33 P, NR 1,2,3,4,6 > 12 months 4 N/A -
Larson 2006 100/200 P+R, NR 1,2,3,5,6 90 days 0 0 6/100 (6%)
Maartense
2004a
30/30 RCT - 30 days 2/30 (6,6%) 3/30 (10%) 0/30 (0%)
Marcello 2000 20/20 P, NR 1,2,3,4,7 D/C 0 0 0/20 (%)
Otani 2001 10/18 NS, NR - D/C 0 0 -
Schmitt 1994 22/20 P, NR 1,2,4 D/C 0 0 -
Totals 253/354* 9/200 (4,5%)
* Larson 2005 was not added up to the total of patients to avoid duplication patient duplication.
ˆ 1: age; 2: gender; 3: BMI; 4: diagnosis; 5: operative technique; 6: date of operation; 7: severity of disease; 8: Duration of follow-up.
Each number indicates that the study had actively matched between the two groups regarding that item.
IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA; R: retrospective; P: prospective; P+R: prospective for the
LA-IPAA group, and retrospective for the open-IPAA group; NS: not specified; NR: non-randomised trial; RCT: randomised controlled
trial; N/A: not applicable; D/C: until discharge
Table 5. Patients characteristics of included studies
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Table 5. Patients characteristics of included studies (Continued)
Araki 2001 21/11 27.2(8.1)ˆ 31.1(11.2)
ˆ
8:13 2:9 31.2(4.5)ˆ 33.1(4.8)ˆ 21:0 11:0
Berdah
2004
12/12 32 (16-60) 31 (21-58) 6:6 6:6 24 (17-29) 22 (20-26) 11:1 11:1
Brown
2001
















4:7 7:6 - - 6:5 6:7
Larson
2005







100/200 32 (17-66) 32 (17-64) 40:60 80:120 22.4 (17-
34)





















- - - - 10:0 18:0
Schmitt
1994
22/20 31 (12-59) 34 (17-64) 11:11 11:9 - - 16:5 + 1
other
15:5
* significant difference; ˆ mean (SD).
IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA; M: male; F: female; UC: ulcerative colitis; FAP: familial
adenomatous polyposis.










Mortality 0 (0%) 0 (0%) NS
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Table 6. Reported outcomes by Maartense 2004 (RCT) (Continued)
Intraoperative complications 1 (3%) 1 (3%) NS
Procedure specific complica-
tions
4 (13%) 6 (20%) NS
Severe postoperative complica-
tions
0 (0%) 2 (7%) NS
Mild postoperative complica-
tions
9 (30%) 7 (23%) NS
Total complications 14 (47%) 16 (53%) NS
Operative time 214 (149 - 400) 133 ( 97 - 260) p=<0.001
Blood loss 263 (75-1200) 300 (50-800) p=0.98
Time to regulat diet 6 (4 - 19) 7 (4 - 15) 0.6
Hospital stay 10 (5 - 13) 11 (6 - 28) 0.767
Readmission 5/23* (22%) 3/23* (13%) NS
Reoperation 5 (17%) 5 (17%) NS
* Only reported in a sub-group of patients (N=23).
IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA. NS = not statistically significant.
Table 7. Available data for defecation frequency and costs.
Outcome N LA-IPAA Open IPAA
DEFECATION
FREQUENCY







- during the day Dunker 2001 15/17 5.70 (1.30) 6.30 (2.00) NS
Larson 2005 33/33 7 (3-14) 6 (3-12) p=0.23*
Maartense 2004 22/23 6.09 (2.29) 5.35 (1.82) p=0.161
- during the night Dunker 2001 15/17 1.0 (0.7) 1.3 (0.7) NS
Larson 2005 33/33 1 (1-5) 2 (1-4) p=0.86*
Maartense 2004 22/23 2.14 (1.91) 1.78 (1.41) p=0.371
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Table 7. Available data for defecation frequency and costs. (Continued)
- per 24 hours Otani 2001 10/18 8.00 (2.3) 11.00 (1.0) NS
COSTS (Euros) Trial LA-IPAA / Open-
IPAA
Mean (SD) Mean (SD) P-value*
- operative costs Maartense 2004a 30/30 3467.35 (290.73) 1755.65 (170.89) p< 0.001





* As provided by author.
IPAA: ileo pouch anal anastomosis; LA-IPAA: laparoscopic (assisted) IPAA
WH A T ’ S N E W
Last assessed as up-to-date: 3 November 2008.
Date Event Description
1 November 2008 Amended Editorial comments have been incorporated into the review
24 April 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 2006
Review first published: Issue 1, 2009
Date Event Description
24 November 2007 New citation required and conclusions have changed Substantive amendment
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• Relative Risks (RR) are used as a summary statistic for dichotomous data in stead of Odds Ratios (OR). The RR were chosen
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